This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other interstitial pulmonary diseases
J10_OTHERINSTPULM
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5925 |
4. Check minimum number of eventsNone |
5925 |
5. Include endpointsNone |
5925 |
6. Filter based on genotype QC (FinnGen only) |
5925 |
Control definitions (FinnGen only)
- Control exclude
- J10_INTERSTITIUM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J80-J84
- Name in latin
- Alii morbi interstitiales pulmonum
Similar endpoints
↥List of similar endpoints to
Other interstitial pulmonary diseases
based on the number of shared cases.
Similar with more cases:
- Interstitial lung disease
- Interstitial lung disease endpoints
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
- Other respiratory diseases principally affecting the interstitium
- Diseases of the respiratory system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5925 | 2347 | 3578 |
| Unadjusted period prevalence (%) | 1.27 | 0.80 | 1.58 |
| Median age at first event (years) | 69.42 | 66.87 | 71.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5266
- Matched controls
- 52661
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.3
323.0
2636
10028
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
389
*
XG410
NOMESCO Finland
Flow-volume spirometry
9.2
323.0
786
987
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
25.2
323.0
1795
1057
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
16384.0
323.0
2518
*
TGC00
NOMESCO Finland
Bronchial lavation
33.6
323.0
1178
447
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.9
323.0
1827
2454
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
21.5
323.0
994
564
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
16384.0
323.0
2752
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.2
323.0
1892
3362
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
467
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
323.0
3455
18272
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
323.0
1440
*
H02AB06
ATC
prednisolone; systemic
5.2
323.0
3854
18183
L04AX05
ATC
pirfenidone; oral
+∞
321.1
305
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
312.4
1185
2979
R06.0
ICD-10 Finland
Dyspnoea
3.3
309.8
2143
9082
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.8
304.8
842
1443
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
10.4
273.5
565
603
R03AC02
ATC
salbutamol; inhalant
2.7
251.5
3125
18507
L04AX01
ATC
azathioprine; systemic
8.3
251.4
595
800
GD1AD
NOMESCO Finland
Thorax CT examination
6.8
240.5
655
1082
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
219.4
2332
12267
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
125.9
213.1
229
19
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.2
209.2
705
1507
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
35.8
208.5
272
80
L01XE31
ATC
[U] nintedanib; oral
+∞
205.5
196
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.3
197.7
658
1382
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
197.6
817
2152
J96.1
ICD-10 Finland
Chronic respiratory failure
8.6
196.4
450
567
L04AA06
ATC
mycophenolic acid; systemic
13.8
178.4
317
243
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
44.3
174.3
217
51
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
168.6
161
*
J01MA14
ATC
moxifloxacin; systemic
3.7
166.6
832
2564
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
162.4
914
3087
48499
ICD-8 Finland
Acute interstitial pneumonia
+∞
150.7
144
*
A02BC02
ATC
pantoprazole; systemic
2.2
144.7
3663
27005
P01BA02
ATC
hydroxychloroquine; oral
3.8
143.0
683
2011
L01EX09
ATC
nintedanib; oral
+∞
136.0
130
*
R03BB04
ATC
tiotropium bromide; inhalant
2.9
135.5
976
3871
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.2
130.3
537
1381
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.2
128.1
529
1362
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.3
122.0
342
572
R05
ICD-10 Finland
Cough
2.4
121.9
1245
5987
C03CA01
ATC
furosemide; systemic
2.0
119.6
2215
13891
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
+∞
118.1
113
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
116.7
1162
5496
M05BA04
ATC
alendronic acid; oral
3.1
116.6
720
2556
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.9
116.4
405
875
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
114.3
1194
5780
GDG10
NOMESCO Finland
Bilateral transplantation of lung
1121.8
113.0
110
*
Z94.2
ICD-10 Finland
Lung transplant status
152.1
112.6
119
8
J01MA12
ATC
levofloxacin; systemic
2.1
96.5
1284
6881
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
10.4
92.0
186
185
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
88.9
1078
5515
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
88.1
1421
8193
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
872.6
87.9
86
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.9
87.8
595
2223
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
87.2
889
4183
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
82.5
690
2917
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.6
81.3
300
685
R4110
NOMESCO Finland
Physiotherapy
1.9
81.0
1521
9233
J47
ICD-10 Finland
Bronchiectasis
5.9
80.5
237
420
J01AA02
ATC
doxycycline; systemic
1.8
80.0
4007
33314
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
10.2
79.9
163
165
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
79.6
469
1591
R03BA08
ATC
ciclesonide; inhalant
3.0
78.8
497
1766
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
78.7
1208
6781
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
77.9
540
2040
J43.9
ICD-10 Finland
Emphysema, unspecified
6.1
77.7
220
371
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
+∞
77.3
74
*
R02
ICPC
Shortness of breath/dyspnoea
2.3
75.5
790
3739
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
75.1
1261
7311
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
74.6
2397
17214
WX892
NOMESCO Finland
Monitored bed care
2.7
73.8
561
2237
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
72.1
1097
6107
R50.9
ICD-10 Finland
Fever, unspecified
2.2
71.9
861
4336
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
71.5
453
1611
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
70.9
1677
10905
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
7.8
68.5
163
215
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
67.5
1168
6803
L04AA13
ATC
leflunomide; oral
5.1
67.1
223
455
J01FA06
ATC
roxithromycin; oral
1.7
66.3
2057
14456
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
65.7
872
4575
R04.2
ICD-10 Finland
Haemoptysis
3.5
65.2
329
991
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
64.8
456
1731
XG466
NOMESCO Finland
Sleep oxymetry
3.8
64.4
286
775
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.6
64.3
307
884
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
24.7
63.3
90
37
L04AD01
ATC
ciclosporin; systemic
6.3
62.9
173
281
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
62.4
1101
6435
H02AB07
ATC
prednisone; oral
2.0
61.9
864
4616
XX4BW
NOMESCO Finland
NA
59.9
60.6
71
12
R03AK08
ATC
formoterol and beclometasone; inhalant
3.8
60.4
272
746
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
60.1
417
1566
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.4
59.2
186
356
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
57.7
1421
9233
Z3226
NOMESCO Finland
Physiotherapist
1.9
57.3
1037
6093
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
57.2
950
5410
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
57.2
481
2021
127
Kela drug reimbursment
Transplant complication
6.8
56.9
148
223
R03AK07
ATC
formoterol and budesonide; inhalant
1.9
56.6
914
5149
WW200
NOMESCO Finland
Immunization
4.2
55.4
219
534
J80
ICD-10 Finland
Adult respiratory distress syndrome
543.5
54.6
54
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
4.5
54.1
202
466
R81
ICPC
Pneumonia
3.6
53.2
256
741
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
5.3
52.8
168
327
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.0
52.8
326
1135
R05
ICPC
Cough
1.8
52.6
1091
6686
ZXE00
NOMESCO Finland
One hour or less
1.6
52.1
1991
14515
J01CA04
ATC
amoxicillin; systemic
1.6
52.0
3782
32271
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
11.3
51.8
99
89
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.1
51.7
170
343
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.7
50.5
232
647
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
7.1
49.9
126
182
ZX120
NOMESCO Finland
Intravenous
2.1
48.9
577
2851
ZX108
NOMESCO Finland
Inhalation
9.6
48.5
101
107
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
7.7
47.0
112
149
Z2221
NOMESCO Finland
Medical doctor
1.6
46.9
1385
9375
R99
ICPC
Respiratory disease other
5.0
46.8
155
316
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.5
46.8
404
1716
GX1K5
NOMESCO Finland
Diffusion capacity
29.0
46.5
63
22
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.5
46.3
226
662
R28
ICPC
Limited function/disability (R)
5.4
46.0
143
271
N02AX02
ATC
tramadol; systemic, rectal
1.5
45.7
2190
16697
A02BC01
ATC
omeprazole; systemic
1.6
45.1
1510
10546
Z3231
NOMESCO Finland
Registered nurse
1.6
44.9
1457
10089
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
44.2
1557
11003
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
43.9
745
4238
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.1
42.8
172
427
R03BA01
ATC
beclometasone; inhalant
1.9
42.4
726
4134
R03BA02
ATC
budesonide; inhalant
1.8
42.4
850
5108
C07AB07
ATC
bisoprolol; oral
1.5
42.4
2696
21745
J84
ICD-10 Finland
Other interstitial pulmonary diseases
216.6
41.9
43
*
WX721
NOMESCO Finland
Oxygen concentrator therapy
24.8
41.9
59
24
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
41.3
969
6108
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
40.9
694
3936
I50.0
ICD-10 Finland
Congestive heart failure
2.0
40.2
561
2958
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.0
39.4
162
411
D86.0
ICD-10 Finland
Sarcoidosis of lung
5.8
39.1
113
197
A02BC05
ATC
esomeprazole; systemic
1.5
38.5
1940
14777
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
37.8
2120
16497
A07AA02
ATC
nystatin; oral
2.2
37.6
392
1822
GDA10
NOMESCO Finland
Biopsy of lung
20.2
37.4
56
28
L88
ICPC
Rheumatoid/seropositive arthritis
3.0
37.3
227
781
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
37.0
1493
10800
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
36.9
514
2704
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.5
36.7
177
515
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.3
36.5
352
1578
R03DC03
ATC
montelukast; oral
1.8
36.5
671
3904
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
60.4
36.1
42
7
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.2
35.9
76
84
WZC30
NOMESCO Finland
Teaching
1.8
35.8
686
4045
J01FA10
ATC
azithromycin; systemic
1.5
35.8
2304
18369
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
28.5
35.5
48
17
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.7
35.0
123
268
GX1D5
NOMESCO Finland
Flow volume spirometry
43.3
35.0
43
10
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.7
34.6
255
990
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.1
34.2
419
2091
J43.8
ICD-10 Finland
Other emphysema
15.7
34.2
56
36
R03BA05
ATC
fluticasone; inhalant
1.7
34.1
839
5332
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.1
33.9
138
347
L04AA01
ATC
[U] ciclosporin; systemic
4.8
33.8
115
243
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
45.9
33.7
41
9
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
33.6
626
3652
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.5
33.6
89
139
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
33.3
367
1751
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
33.2
959
6364
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
17.5
33.1
52
30
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
5.4
32.8
101
191
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
32.7
391
1932
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
32.7
549
3092
JN4BD
NOMESCO Finland
Extensive body CT
1.8
32.4
634
3754
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
32.4
600
3492
G47.3
ICD-10 Finland
Sleep apnoea
1.6
32.2
974
6538
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
32.1
557
3168
M05BA07
ATC
risedronic acid; oral
2.8
31.8
214
786
A03
ICPC
Fever
1.8
31.4
574
3323
J01FF01
ATC
clindamycin; systemic
1.5
31.4
1254
8985
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
31.1
259
1074
E0000UV
ATC
NA
1.4
31.0
1754
13513
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
7.6
30.9
73
97
M34.1
ICD-10 Finland
CR(E)ST syndrome
12.3
30.9
56
46
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.2
30.7
166
528
M01CB01
ATC
sodium aurothiomalate; parenteral
4.3
30.6
115
269
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
30.6
268
1142
J94.1
ICD-10 Finland
Fibrothorax
46.5
30.6
37
8
Z2446
NOMESCO Finland
Social worker
2.2
30.4
325
1527
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
29.7
254
1071
J20
ICD-10 Finland
Acute bronchitis
1.9
29.7
446
2410
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.1
29.7
117
287
D07AC01
ATC
betamethasone; topical
1.4
29.2
1605
12257
2AX04
NOMESCO Finland
NA
80.5
28.7
32
*
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
17.4
28.7
45
26
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
33.8
28.7
37
11
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
29.4
28.5
38
13
XX9XE
NOMESCO Finland
Other ultrasound examination
6.0
28.4
80
136
N02BE01
ATC
paracetamol; systemic, rectal
1.5
28.3
4203
38352
F1246
NOMESCO Finland
NA
14.8
28.2
47
32
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.6
28.0
131
373
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
7.6
27.9
66
88
J96.0
ICD-10 Finland
Acute respiratory failure
4.0
27.8
114
290
L04AB01
ATC
etanercept; parenteral
5.4
27.8
85
160
R06.2
ICD-10 Finland
Wheezing
2.5
27.8
226
928
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
27.7
1773
13905
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
7.2
27.7
68
96
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.4
27.4
137
411
WX722
NOMESCO Finland
PEEP
2.2
27.3
276
1263
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
27.1
338
1695
A02BC03
ATC
lansoprazole; oral
1.4
27.1
1445
10935
XJC10
NOMESCO Finland
Oesophageal pH monitoring
8.5
26.9
59
70
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
26.9
1259
9280
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
26.9
374
1961
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
26.8
530
3142
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.8
26.7
179
655
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
26.5
268
1227
A01AB09
ATC
miconazole; local oral
1.9
26.5
444
2492
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
26.1
1436
10923
XG460
NOMESCO Finland
Short time oxymetry
3.3
26.1
135
417
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
25.7
895
6178
WX726
NOMESCO Finland
High-flow oxygen therapy
21.9
25.6
37
17
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
25.5
1839
14673
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
25.4
710
4638
H02AB04
ATC
methylprednisolone; systemic
1.6
25.2
693
4507
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
+∞
25.0
24
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
24.9
275
1312
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.8
24.6
57
74
5AB14
NOMESCO Finland
NA
32.2
24.6
32
10
L01AA01
ATC
cyclophosphamide; systemic
8.0
24.6
56
71
WX872
NOMESCO Finland
Intensive care
2.1
24.6
298
1480
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
24.4
1918
15502
M04AA01
ATC
allopurinol; systemic
1.6
24.3
810
5525
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.3
24.3
124
379
Z51.5
ICD-10 Finland
Palliative care
1.9
24.2
373
2028
J01DB01
ATC
cefalexin; oral
1.4
24.2
3819
34516
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
24.2
1536
11957
L04AB04
ATC
adalimumab; parenteral
4.2
24.2
93
224
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
24.1
1682
13313
R06AE07
ATC
cetirizine; oral
1.4
24.0
1742
13873
3A006
NOMESCO Finland
NA
+∞
24.0
23
*
N03AX16
ATC
pregabalin; oral
1.5
23.7
1074
7837
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
12.0
23.7
43
36
B01AA03
ATC
warfarin; systemic
1.4
23.7
1286
9721
J45.8
ICD-10 Finland
Mixed asthma
2.7
23.4
168
644
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
23.3
503
3059
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
10.5
23.2
45
43
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
23.2
418
2399
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
22.7
333
1780
F2680
NOMESCO Finland
NA
11.4
22.6
42
37
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
22.5
295
1512
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
22.3
1388
10735
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.4
22.2
199
860
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
22.1
685
4583
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
22.1
751
5139
WZA10
NOMESCO Finland
Long statement of health and health related matters
4.3
22.1
83
196
R03AK11
ATC
formoterol and fluticasone; inhalant
3.0
22.0
129
437
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.3
21.9
111
338
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
21.9
234
1100
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
+∞
21.9
21
*
AN1
HP
Coronary angiography
1.5
21.8
732
4990
M34.0
ICD-10 Finland
Progressive systemic sclerosis
29.1
21.8
29
10
GAA31
NOMESCO Finland
Thoracoscopy
8.9
21.7
46
52
J01FA15
ATC
telithromycin; oral
1.8
21.7
424
2496
J81
ICD-10 Finland
Pulmonary oedema
38.8
21.7
27
7
RS123
NOMESCO Finland
NA
20.1
21.6
32
16
C01DA14
ATC
isosorbide mononitrate; oral
1.5
21.6
1017
7457
WX110
NOMESCO Finland
Local anesthesy
1.3
21.5
2888
25176
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.0
21.4
86
217
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
5.8
21.4
61
107
J43.2
ICD-10 Finland
Centrilobular emphysema
8.3
21.3
47
57
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
17.5
21.3
33
19
J01FA09
ATC
clarithromycin; systemic
1.4
21.2
1237
9444
J99.0
ICD-10 Finland
Rheumatoid lung disease
60.2
20.9
24
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
19.5
20.8
31
16
J67.0
ICD-10 Finland
Farmer lung
19.5
20.8
31
16
R03AC03
ATC
terbutaline; inhalant
1.6
20.7
589
3856
XG405
NOMESCO Finland
Education on PEF monitoring
3.4
20.7
101
300
JN4AD
NOMESCO Finland
Body CT examination
1.7
20.6
411
2437
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
20.5
1206
9210
UJF32
NOMESCO Finland
Coloscopy
1.4
20.5
1275
9834
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.9
20.5
129
457
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.7
20.3
145
554
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
48.2
20.1
24
5
N02AA05
ATC
oxycodone; systemic
1.5
20.0
789
5568
SPAT1325
SPAT
Vaccination
1.3
20.0
1751
14274
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
7.7
20.0
46
60
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
20.0
450
2766
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
20.8
19.9
29
14
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
19.8
684
4687
Z57.2
ICD-10 Finland
Occupational exposure to dust
7.0
19.8
49
71
L04AA24
ATC
abatacept; parenteral
9.6
19.8
40
42
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
19.6
727
5064
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.1
19.5
240
1198
J46
ICD-10 Finland
Status asthmaticus
2.7
19.5
138
527
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
19.5
284
1516
RK320
NOMESCO Finland
NA
4.3
19.5
73
173
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
21.6
19.5
28
13
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
4.4
19.4
71
164
SPAT1262
SPAT
Handing over of treatment supplies
1.4
19.4
938
6897
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.1
19.4
109
360
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
19.4
1172
8981
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
4.8
19.3
65
138
M35.1
ICD-10 Finland
Other overlap syndromes
7.8
19.2
44
57
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
19.2
1281
9982
J05AB11
ATC
valaciclovir; oral
1.6
19.1
548
3592
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
19.1
522
3381
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.9
19.0
276
1470
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.9
18.9
302
1666
SPAT1263
SPAT
Sampling
1.3
18.7
1908
15868
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.8
18.5
61
127
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.1
18.4
209
1010
J12.8
ICD-10 Finland
Other viral pneumonia
4.9
18.3
60
124
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.9
18.3
116
412
ZXD05
NOMESCO Finland
Urgent procedure
1.3
18.3
1410
11231
D07AC13
ATC
mometasone; topical
1.4
18.3
1234
9619
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.9
18.2
59
121
E000001
ATC
NA
1.4
18.1
844
6153
RK110
NOMESCO Finland
NA
4.6
18.1
63
139
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
5.1
18.1
57
113
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
18.1
357
2110
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
18.1
268
1438
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
3.4
18.0
87
257
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
18.0
204
986
M33.2
ICD-10 Finland
Polymyositis
10.1
17.8
35
35
C09AA05
ATC
ramipril; oral
1.3
17.8
1355
10760
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
17.8
381
2306
R01AD12
ATC
fluticasone furoate; nasal
1.4
17.8
966
7250
XQ800
NOMESCO Finland
Prick test
2.0
17.8
242
1261
J15.8
ICD-10 Finland
Other bacterial pneumonia
4.5
17.8
63
142
GX2C5
NOMESCO Finland
Short-lasting oximetry
18.1
17.7
27
15
ZXA10
NOMESCO Finland
Bilateral
1.4
17.6
900
6676
R03DA04
ATC
theophylline; systemic, rectal
1.8
17.6
321
1852
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.5
17.5
136
549
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
17.4
415
2589
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.5
17.4
142
588
WX002
NOMESCO Finland
Sedation and analgesia
1.4
17.3
931
6972
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.1
17.3
93
299
C03DA01
ATC
spironolactone; oral
1.5
17.2
576
3916
M05BX04
ATC
denosumab; parenteral
1.9
17.2
253
1356
R03BB01
ATC
ipratropium bromide; inhalant
1.9
17.1
259
1401
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
17.1
1032
7881
GD1UN
NOMESCO Finland
Lung circulation SPECT
4.9
17.0
55
113
R4190
NOMESCO Finland
Nutritional therapy
2.5
16.8
137
564
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
16.8
295
1680
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
5.5
16.7
49
90
J01DA01
ATC
[U] cefalexin; systemic
1.3
16.7
2835
25112
J18
ICD-10 Finland
Pneumonia, organism unspecified
4.3
16.6
61
143
XF402
NOMESCO Finland
ECG with work load test
1.5
16.5
564
3848
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
16.5
372
2283
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
6.8
16.4
41
61
B02.9
ICD-10 Finland
Zoster without complication
1.8
16.4
283
1600
XPX04
NOMESCO Finland
Angioscopy
8.6
16.4
35
41
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
16.4
245
1323
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
14.3
16.3
27
19
R01AD09
ATC
mometasone; nasal
1.3
16.2
1660
13735
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
16.2
1268
10086
GX2D5
NOMESCO Finland
Sleep oximetry
10.4
16.1
31
30
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
16.1
493
3280
R29
ICPC
Respiratory symptom/complaint other
1.9
16.0
256
1414
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.3
16.0
42
67
I73.0
ICD-10 Finland
Raynaud syndrome
3.4
15.8
75
220
M33.1
ICD-10 Finland
Other dermatomyositis
14.5
15.8
26
18
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
60.2
15.7
18
*
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.4
15.7
131
549
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.4
15.7
134
570
AK3
HP
BLTX (both lung transplants)
+∞
15.6
15
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
15.6
100
359
R03AC13
ATC
formoterol; inhalant
1.9
15.6
236
1277
J01MA02
ATC
ciprofloxacin; systemic
1.3
15.6
1893
16007
5BA08
NOMESCO Finland
NA
5.1
15.5
48
94
M25.5
ICD-10 Finland
Pain in joint
1.4
15.5
1052
8177
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
15.4
1377
11157
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
15.4
1371
11102
A28
ICPC
Limited function/disability NOS
1.4
15.4
828
6181
1CX01
NOMESCO Finland
NA
12.3
15.3
27
22
J96.9
ICD-10 Finland
Respiratory failure, unspecified
4.7
15.3
51
109
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
5.1
15.2
47
92
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
4.8
15.2
50
105
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.9
15.2
239
1313
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.5
15.2
512
3481
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
8.7
15.2
32
37
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
15.2
256
1442
N03AX12
ATC
gabapentin; oral
1.5
15.1
642
4585
M05.1
ICD-10 Finland
Rheumatoid lung disease
45.1
15.0
18
*
ZXA00
NOMESCO Finland
Right side
1.3
15.0
1310
10577
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
15.0
368
2315
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
3.8
14.9
63
168
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
14.9
322
1952
J98.4
ICD-10 Finland
Other disorders of lung
10.8
14.9
28
26
N05CF01
ATC
zopiclone; oral
1.3
14.9
1549
12810
R03AC12
ATC
salmeterol; inhalant
1.8
14.8
247
1383
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
31.8
14.8
19
6
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.6
14.8
111
439
M10.9
ICD-10 Finland
Gout, unspecified
1.6
14.6
374
2377
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
14.6
14
*
H02AB09
ATC
hydrocortisone; systemic
2.7
14.6
100
378
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
14.4
236
1313
WX882
NOMESCO Finland
High dependency care
2.2
14.4
145
668
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.3
14.4
72
221
N02AA01
ATC
morphine; systemic, rectal
2.7
14.2
94
347
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.5
14.2
114
467
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
19.2
14.2
21
11
TGD00
NOMESCO Finland
Needle biopsy of lung
5.2
14.2
43
83
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.4
14.1
123
527
SPAT1255
SPAT
Intravenous administration of medicine
1.7
14.1
312
1909
J45
ICD-10 Finland
Asthma
1.6
14.0
362
2308
M31.3
ICD-10 Finland
Wegener granulomatosis
6.6
14.0
35
53
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
14.0
345
2174
81
HP
Angiography of the heart and coronary arteries
1.6
13.9
410
2701
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
13.9
630
4551
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
13.9
365
2334
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
13.9
393
2563
D07AB08
ATC
desonide; topical
1.5
13.9
439
2941
J93.8
ICD-10 Finland
Other pneumothorax
5.2
13.9
42
81
1240
FHL
Bronchoscopy
2.9
13.9
83
289
J02AC01
ATC
fluconazole; systemic
1.3
13.8
1346
11015
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
13.8
168
838
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
13.7
297
1807
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
13.7
323
2011
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.0
13.6
76
253
R74
ICPC
Upper respiratory infection acute
1.4
13.6
805
6105
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.1
13.6
144
680
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
75.3
13.6
15
*
R4120
NOMESCO Finland
Occupational therapy
1.7
13.5
264
1560
J01GB01
ATC
tobramycin; inhalant, parenteral
25.8
13.3
18
7
A46
ICD-10 Finland
Erysipelas
1.4
13.2
675
4987
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.0
13.2
162
813
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
13.2
115
496
1XC02
NOMESCO Finland
NA
3.9
13.1
53
137
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
12.1
13.1
23
19
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.4
13.0
62
184
B01AB05
ATC
enoxaparin; parenteral
1.3
13.0
1398
11568
M54.5
ICD-10 Finland
Low back pain
1.3
13.0
1244
10143
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
28.4
12.9
17
6
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
9.3
12.9
26
28
4040
NOMESCO Finland
NA
19.1
12.9
19
10
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
4.9
12.9
41
84
C10AA03
ATC
pravastatin; oral
1.6
12.8
373
2450
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.9
12.7
193
1046
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.0
12.7
163
833
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.2
12.7
66
209
D07XC01
ATC
betamethasone, combinations; topical
1.5
12.7
534
3800
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
10.5
12.7
24
23
291
Kela drug reimbursment
Tofacitinib
10.5
12.7
24
23
J02AC03
ATC
voriconazole; systemic
9.7
12.7
25
26
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
6.8
12.6
31
46
M79.6
ICD-10 Finland
Pain in limb
1.3
12.6
1458
12175
WX740
NOMESCO Finland
Nitrogen oxide therapy
12.3
12.6
22
18
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
12.5
461
3194
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.8
12.5
225
1292
304
Kela drug reimbursment
Dornase alfa
+∞
12.5
12
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
12.5
12
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.9
12.4
168
876
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
12.4
1355
11231
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
12.4
353
2309
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
12.3
1907
16472
RS230
NOMESCO Finland
NA
5.6
12.3
35
63
WX402
NOMESCO Finland
General anaesthesia
1.4
12.2
598
4381
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
10.5
12.2
23
22
L04AA17
ATC
[U] adalimumab; parenteral
7.4
12.2
28
38
R01AD08
ATC
fluticasone; nasal
1.3
12.1
1031
8254
ZY010
NOMESCO Finland
Hospital outpatient
2.0
12.1
149
748
A01AB04
ATC
amphotericin B; local oral
1.8
12.1
225
1307
R05FB02
ATC
cough suppressants and expectorants
1.3
12.1
1713
14639
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.8
12.0
197
1099
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
12.0
529
3798
318
Kela drug reimbursment
Teriparatide
4.5
12.0
41
91
51709
ICD-8 Finland
Other chronic interstitial pneumonia, Unspecified
21.3
12.0
17
8
L03
ICPC
Low back symptom/complaint
1.3
11.9
899
7071
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.8
11.9
74
264
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
46.7
11.9
14
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
11.8
214
1235
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
11.8
1377
11492
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
14.7
11.8
19
13
ZXA05
NOMESCO Finland
Left side
1.3
11.7
1201
9852
J94.8
ICD-10 Finland
Other specified pleural conditions
2.4
11.7
96
402
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
11.7
280
1751
L04AB06
ATC
golimumab; parenteral
5.7
11.6
32
56
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
11.5
845
6615
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.8
11.5
187
1042
WX720
NOMESCO Finland
Own respiration
1.9
11.5
161
851
R2110
NOMESCO Finland
Giving the first information
1.7
11.5
245
1483
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
8.6
11.5
24
28
I50.1
ICD-10 Finland
Left ventricular failure
1.6
11.5
268
1663
B01AC04
ATC
clopidogrel; oral
1.3
11.4
856
6722
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
11.4
1431
12033
M05BA06
ATC
ibandronic acid; systemic
2.4
11.4
95
402
J01FA01
ATC
erythromycin; systemic
1.5
11.4
437
3049
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
120.2
11.4
12
*
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
3.2
11.3
58
183
NG1DA
NOMESCO Finland
X-ray of knees
2.5
11.3
86
344
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
11.3
536
3904
S97
ICPC
Chronic ulcer skin
1.6
11.2
269
1681
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.9
11.1
66
230
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
25.0
11.1
15
6
ZX197
NOMESCO Finland
NA
20.0
11.1
16
8
I27.0
ICD-10 Finland
Primary pulmonary hypertension
6.8
11.1
27
40
A02BA02
ATC
ranitidine; systemic
1.3
11.1
941
7523
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.8
11.1
175
965
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
8.0
11.0
24
30
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.4
11.0
91
382
M01CB03
ATC
auranofin; oral
3.5
11.0
49
139
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
5.8
11.0
30
52
N07BA03
ATC
varenicline; oral
1.9
11.0
153
809
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
10.9
184
1038
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
4.8
10.9
35
73
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
10.9
328
2170
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.8
10.9
69
250
Z94.3
ICD-10 Finland
Heart and lungs transplant status
43.4
10.9
13
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.6
10.8
278
1773
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
10.8
853
6750
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
10.6
10.7
20
19
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
10.7
702
5399
L01CB
ATC
Podophyllotoxin derivatives
7.2
10.7
25
35
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.7
10.7
45
122
E000003
ATC
NA
1.8
10.7
174
969
J42
ICD-10 Finland
Unspecified chronic bronchitis
2.6
10.7
75
289
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
7.5
10.6
24
32
H26.3
ICD-10 Finland
Drug-induced cataract
4.5
10.6
36
80
J05AB01
ATC
aciclovir; systemic
1.3
10.6
807
6349
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.2
10.5
53
166
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.1
10.5
115
554
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.7
10.5
44
119
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
10.5
608
4583
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.2
10.4
104
480
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
7.3
10.4
24
33
L04AC07
ATC
tocilizumab; parenteral
7.3
10.4
24
33
R24
ICPC
Haemoptysis
3.8
10.4
43
115
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
+∞
10.4
10
*
51701
ICD-8 Finland
Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)
+∞
10.4
10
*
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
2.7
10.4
68
253
H05AA02
ATC
teriparatide; parenteral
4.4
10.4
36
82
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.0
10.3
127
641
I25.2
ICD-10 Finland
Old myocardial infarction
1.5
10.3
411
2896
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.6
10.2
44
122
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
5.5
10.2
29
53
S18
ICPC
Laceration/cut
1.2
10.2
1897
16624
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.6
10.2
286
1865
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.0
10.2
39
98
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
10.2
366
2526
L04AB05
ATC
certolizumab pegol; parenteral
7.4
10.2
23
31
N06AX11
ATC
mirtazapine; oral
1.3
10.1
1251
10474
E000002
ATC
NA
1.5
10.1
394
2762
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
10.1
107
508
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
10.0
226
1394
L04AA29
ATC
tofacitinib; oral
8.4
10.0
21
25
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.3
10.0
90
396
L04AA11
ATC
[U] etanercept; parenteral
6.4
10.0
25
39
FXE00
NOMESCO Finland
Use of ECLA
40.1
10.0
12
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
12.2
9.8
17
14
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
9.8
256
1639
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
9.8
605
4607
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
9.8
325
2201
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.4
9.8
80
337
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
4.2
9.7
35
83
SBA10
NOMESCO Finland
Measurement of excretion of saliva
3.4
9.7
46
138
B37.0
ICD-10 Finland
Candidal stomatitis
3.4
9.7
46
138
A02BA03
ATC
famotidine; systemic
1.7
9.7
201
1212
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.6
9.7
126
2146
TK800
NOMESCO Finland
Hemodialysis
2.1
9.7
103
489
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
3.7
9.6
40
108
Z71.8
ICD-10 Finland
Other specified counselling
1.3
9.6
846
6783
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.2
9.6
98
458
R04.0
ICD-10 Finland
Epistaxis
1.5
9.6
349
2415
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
9.6
168
962
N18.8
ICD-10 Finland
Other chronic renal failure
1.8
9.6
151
835
D02AE01
ATC
carbamide; topical
1.6
9.5
259
1677
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
4.1
9.5
35
85
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
9.5
359
2502
R03AC19
ATC
olodaterol; inhalant
4.0
9.5
36
90
-1
NOMESCO Finland
NA
1.3
9.5
1120
9320
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.2
9.5
93
429
D72.1
ICD-10 Finland
Eosinophilia
5.4
9.5
27
50
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.6
9.5
41
115
ED1AA
NOMESCO Finland
Mandipular X-ray examination
3.8
9.5
38
100
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.5
9.5
71
284
XF404
NOMESCO Finland
Ambulatory ECG
1.4
9.4
429
3100
NDG30
NOMESCO Finland
Fusion of wrist, total
4.2
9.4
34
81
H03AA01
ATC
levothyroxine sodium; systemic
1.3
9.4
895
7249
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
30.0
9.4
12
*
J01XB01
ATC
colistin; inhalant, parenteral
30.0
9.4
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.4
9.4
74
305
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.0
9.4
51
170
R96
ICPC
Asthma
1.5
9.4
323
2210
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
9.4
1162
9727
C02KX01
ATC
bosentan; oral
21.7
9.3
13
6
R95
ICPC
Chron obstructive pulmonary disease
1.9
9.3
139
754
SPAT1260
SPAT
Consultation of another employee
1.3
9.3
763
6061
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.8
9.3
158
895
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
10.7
9.3
17
16
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
3.7
9.3
38
102
A04
ICPC
Weakness/tiredness general
1.4
9.2
528
3974
132
Kela drug reimbursment
Sarcoidosis
3.4
9.2
42
123
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.5
9.2
308
2091
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
9.2
354
2476
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.5
9.2
269
1772
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
5.4
9.2
26
48
XF622
NOMESCO Finland
Measurement of minute volume of heart
5.4
9.2
26
48
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.8
9.2
166
960
3AC01
NOMESCO Finland
NA
3.0
9.1
51
173
P01AB01
ATC
metronidazole; oral, rectal
1.2
9.1
1496
12902
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
9.1
1676
14627
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.6
9.1
62
237
Z31.5
ICD-10 Finland
Genetic counselling
1.9
9.1
125
659
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
6.2
9.1
23
37
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
6.2
9.1
23
37
B59
ICD-10 Finland
Pneumocystosis
11.5
9.0
16
14
I50
ICD-10 Finland
Heart failure
1.7
9.0
169
990
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
5.9
9.0
24
41
C02KX04
ATC
macitentan; oral
15.6
9.0
14
9
R03BB07
ATC
umeclidinium bromide; inhalant
3.1
9.0
48
158
R60.0
ICD-10 Finland
Localized oedema
1.4
9.0
493
3685
C08CA05
ATC
nifedipine; systemic
1.5
9.0
331
2294
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.9
8.9
134
728
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.2
8.9
88
405
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.0
8.9
105
523
J37.0
ICD-10 Finland
Chronic laryngitis
1.9
8.9
128
686
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
24.0
8.9
12
5
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
8.9
364
2579
6BA02
NOMESCO Finland
NA
6.1
8.9
23
38
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
8.9
83
1542
M06
ICD-10 Finland
Other rheumatoid arthritis
3.6
8.9
38
106
TNG10
NOMESCO Finland
Puncture of knee
2.9
8.9
52
182
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.6
8.8
253
1658
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
8.8
1047
8706
D07AA02
ATC
hydrocortisone; topical
1.4
8.8
477
3554
RK250
NOMESCO Finland
NA
3.8
8.8
35
92
RK310
NOMESCO Finland
NA
10.7
8.8
16
15
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
10.7
8.8
16
15
J98.2
ICD-10 Finland
Interstitial emphysema
10.7
8.8
16
15
RS221
NOMESCO Finland
NA
2.5
8.8
65
262
R53
ICD-10 Finland
Malaise and fatigue
1.3
8.7
852
6922
A91
ICPC
Abnormal result investigation NOS
1.7
8.7
174
1037
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.5
8.7
67
275
L95
ICPC
Osteoporosis
1.9
8.7
130
707
J43.1
ICD-10 Finland
Panlobular emphysema
14.0
8.7
14
10
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
50.1
8.7
10
*
M01AB55
ATC
diclofenac, combinations; oral
1.5
8.7
306
2105
XX7LW
NOMESCO Finland
NA
6.6
8.6
21
32
K76.9
ICD-10 Finland
Liver disease, unspecified
2.7
8.6
56
209
NDL52
NOMESCO Finland
Tenosynovectomy of hand
3.7
8.6
36
99
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
3.3
8.6
40
120
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
6.9
8.5
20
29
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.9
8.5
121
648
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.5
8.5
275
1857
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
8.5
196
1220
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.5
8.5
295
2021
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.1
8.5
90
429
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
27.5
8.5
11
*
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
27.5
8.5
11
*
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
8.4
495
3736
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
6.0
8.4
22
37
4038
NOMESCO Finland
NA
90.2
8.4
9
*
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
90.2
8.4
9
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.2
8.4
79
356
XA421
NOMESCO Finland
Nocturnal polygraphy
4.8
8.3
26
54
ZX114
NOMESCO Finland
Intramuscular
2.4
8.3
65
269
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
8.3
1632
14302
5168X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies
+∞
8.3
8
*
SBA00
NOMESCO Finland
Microbiological examinations
2.1
8.3
94
462
D07AD01
ATC
clobetasol; topical
1.3
8.3
582
4515
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.5
8.3
64
262
UGC02
NOMESCO Finland
Rigid bronchoscopy
5.5
8.3
23
42
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.7
8.2
345
4653
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.9
8.2
108
561
ZX121
NOMESCO Finland
Central venous catheter
4.9
8.2
25
51
N06AA09
ATC
amitriptyline; systemic
1.4
8.2
403
2958
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
4.5
8.1
27
60
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.3
8.1
69
297
R13
ICD-10 Finland
Dysphagia
1.5
8.1
270
1836
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.4
8.1
63
260
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.6
8.1
225
1469
N06AX16
ATC
venlafaxine; oral
1.4
8.1
387
2824
293
Kela drug reimbursment
Baricitinib
8.1
8.1
17
21
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
8.1
444
3319
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
11.7
8.1
14
12
WVA20
NOMESCO Finland
Medicine administration
2.0
8.0
94
468
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
8.0
129
722
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
22.0
8.0
11
5
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
22.0
8.0
11
5
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
8.0
474
3589
K07
ICPC
Swollen ankles/oedema
1.6
8.0
197
1249
ZX100
NOMESCO Finland
Oral
2.3
8.0
72
322
UDC00
NOMESCO Finland
Ear microscopy
1.5
8.0
293
2035
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.7
8.0
328
4436
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.3
8.0
66
283
S22.3
ICD-10 Finland
Fracture of rib
1.5
7.9
274
1877
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
7.9
321
2271
R06AX27
ATC
desloratadine; oral
1.3
7.9
792
6447
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.7
7.9
170
1035
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.4
7.9
325
2306
M02AA07
ATC
piroxicam; topical
1.2
7.9
1611
14149
WX730
NOMESCO Finland
Conventional respirator
2.2
7.9
77
356
DHA10
NOMESCO Finland
Biopsy of cavity of nose
3.3
7.9
38
117
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.7
7.9
158
944
TFP20
NOMESCO Finland
Cardiodefibrillation
1.4
7.9
363
2627
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
3.7
7.9
32
86
3006
Kela drug reimbursment
Baricitinib
7.7
7.9
17
22
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
7.8
1315
11336
3005
Kela drug reimbursment
Tofacitinib
8.4
7.8
16
19
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
7.8
428
3198
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
7.8
177
1100
S29
ICPC
Skin symptom/complaint other
1.3
7.8
672
5369
AA1AD
NOMESCO Finland
CT of head and brain
1.2
7.8
1124
9545
R63.4
ICD-10 Finland
Abnormal weight loss
1.7
7.7
155
930
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
4.0
7.7
29
73
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.7
7.7
139
807
T90
ICPC
Diabetes non-insulin dependent
1.2
7.7
1053
8884
XX1VW
NOMESCO Finland
Written report from radiologist
3.3
7.7
36
109
R76.0
ICD-10 Finland
Raised antibody titre
6.3
7.7
19
30
A02BA04
ATC
nizatidine; systemic
1.4
7.7
356
2584
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
7.7
451
3406
M48.0
ICD-10 Finland
Spinal stenosis
1.3
7.7
570
4462
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.7
2774
25598
XX4AW
NOMESCO Finland
NA
7.4
7.7
17
23
J86.9
ICD-10 Finland
Pyothorax without fistula
2.7
7.7
49
181
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.1
7.6
39
126
R03BB06
ATC
glycopyrronium bromide; inhalant
3.5
7.6
33
94
UDM02
NOMESCO Finland
Sinoscopy
2.1
7.6
79
374
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.7
7.6
167
1024
L28
ICPC
Limited function/disability (L)
1.3
7.6
725
5864
L17
ICPC
Foot/toe symptom/complaint
1.2
7.6
1005
8446
B01AF02
ATC
apixaban; oral
1.3
7.6
473
3608
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
18.4
7.6
11
6
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
7.6
305
2156
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.3
7.6
35
105
L04AA37
ATC
baricitinib; oral
8.0
7.6
16
20
R06AX22
ATC
ebastine; oral
1.3
7.6
527
4087
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.3
7.6
63
271
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.5
7.5
33
95
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.6
7.5
184
1161
5823
FHL
Lung avobiopsy and wedge resection
8.8
7.5
15
17
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.5
2308
20994
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
10.0
7.5
14
14
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
7.5
643
5135
207
Kela drug reimbursment
Chronic arrhythmias
1.3
7.5
764
6235
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.2
7.5
68
305
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
7.5
1028
8678
L57.0
ICD-10 Finland
Actinic keratosis
1.3
7.5
486
3731
R01
ICPC
Pain respiratory system
2.6
7.4
52
204
K29.7
ICD-10 Finland
Gastritis, unspecified
1.7
7.4
148
886
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.5
7.4
217
1435
UJD02
NOMESCO Finland
Gastroscopy
1.5
7.4
208
1364
A06AD11
ATC
lactulose; oral
1.3
7.4
708
5732
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.3
2004
18036
J98.6
ICD-10 Finland
Disorders of diaphragm
4.0
7.3
27
67
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
7.3
900
7503
RS220
NOMESCO Finland
NA
2.4
7.3
58
243
SPAT1059
SPAT
Spirometry at the office
1.5
7.3
216
1431
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
7.3
380
2816
WW500
NOMESCO Finland
Blood transfusion
1.6
7.3
172
1079
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
4.5
7.2
24
54
A07EC02
ATC
mesalazine; oral, rectal
1.6
7.2
184
1174
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.8
7.2
108
590
D68.8
ICD-10 Finland
Other specified coagulation defects
3.1
7.2
36
115
-44
ICPC
Preventive immunization/medic
1.4
7.2
369
2724
SPAT1310
SPAT
Counselling related to known health issue
1.2
7.2
1300
11277
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
7.2
2024
18258
R03BB05
ATC
aclidinium bromide; inhalant
4.1
7.2
26
64
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.7
7.1
139
829
HA1AA
NOMESCO Finland
X-ray mammography
1.5
7.1
227
1533
R5599
NOMESCO Finland
Other rehabilitation service
1.9
7.1
99
529
602
Kela drug reimbursment
Children's severe malnutrition
12.0
7.1
12
10
A01
ICPC
Pain general/multiple sites
1.4
7.1
284
2009
C10AX09
ATC
ezetimibe; oral
1.3
7.1
454
3480
L01BB01
ATC
NA
5.6
7.0
19
34
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
10.0
7.0
13
13
N19
ICD-10 Finland
Unspecified kidney failure
1.6
7.0
169
1065
S22.2
ICD-10 Finland
Fracture of sternum
3.3
7.0
32
96
NXL00
NOMESCO Finland
Biopsy of muscle
4.7
7.0
22
47
F03
ICD-10 Finland
Unspecified dementia
0.6
7.0
88
1507
L02AE02
ATC
leuprorelin; implant, parenteral
0.6
7.0
118
1882
K51.8
ICD-10 Finland
Other ulcerative colitis
2.6
7.0
47
182
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
2.9
7.0
40
138
J32.4
ICD-10 Finland
Chronic pansinusitis
2.5
7.0
52
210
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.1
6.9
35
113
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
3.8
6.9
27
71
B01AB04
ATC
dalteparin; parenteral
1.5
6.9
216
1450
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.9
1712
15267
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.5
6.9
261
1825
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.1
6.9
76
370
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.5
6.9
193
1263
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.0
6.9
79
394
M10
ICD-10 Finland
Gout
1.5
6.9
205
1361
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
13.8
6.9
11
8
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
6.9
428
3263
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.9
6.9
89
462
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.5
6.8
49
196
ZX140
NOMESCO Finland
Intra articular
2.8
6.8
40
142
J01DA06
ATC
[U] cefuroxime; systemic
1.3
6.8
543
4294
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
40.1
6.8
8
*
RT272
NOMESCO Finland
NA
5.6
6.7
18
32
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
16.7
6.7
10
6
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
6.7
427
3267
ZY000
NOMESCO Finland
Hospital inpatient
3.2
6.7
33
105
B07.9
ICD-10 Finland
Verruca simplex
1.8
6.7
104
579
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
7.2
6.7
15
21
D11
ICPC
Diarrhoea
1.4
6.7
324
2371
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.7
6.7
43
160
XJC00
NOMESCO Finland
Oesophageal manometry
4.1
6.7
24
59
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
1.9
6.6
97
528
116
Kela drug reimbursment
Prostate cancer
0.7
6.6
188
2701
WNF00
NOMESCO Finland
Infection source and contact determination
3.4
6.6
29
85
XX9XW
NOMESCO Finland
NA
3.4
6.6
29
85
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.4
6.6
53
224
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.6
1645
14664
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.1
6.6
65
306
ZXX09
NOMESCO Finland
Extent of procedure, more than 8 units
8.7
6.5
13
15
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.5
6.5
186
1224
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
6.5
2630
24338
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.6
6.5
43
165
R49.01
ICD-10 Finland
Functional dysphonia
1.8
6.5
100
554
KMAK
NOMESCO Finland
NA
1.2
6.4
1810
16286
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.3
6.4
55
240
UGC08
NOMESCO Finland
Rigid bronchoscopy with biopsy of lung
69.9
6.4
7
*
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
69.9
6.4
7
*
GD1LA
NOMESCO Finland
GD
2.1
6.4
66
315
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.7
6.4
209
2936
N06DA03
ATC
rivastigmine; oral, transdermal
0.6
6.4
70
1243
1243
FHL
Bronchoscopy and other therapeutic procedure
7.4
6.4
14
19
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
14.3
6.4
10
7
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.0
6.4
75
378
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
6.4
918
7778
D06BB04
ATC
podophyllotoxin; topical
1.8
6.4
103
582
GDB10
NOMESCO Finland
Wedge resection of lung
6.5
6.3
15
23
RS310
NOMESCO Finland
NA
8.1
6.3
13
16
N06DA02
ATC
donepezil; oral
0.6
6.3
129
1974
C01AA05
ATC
digoxin; systemic
1.3
6.3
459
3585
A11
ICPC
Chest pain NOS
1.4
6.3
301
2203
R01AD01
ATC
beclometasone; nasal
1.3
6.3
517
4106
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.5
6.3
223
1542
C10AA05
ATC
atorvastatin; oral
1.2
6.3
1855
16746
L08
ICPC
Shoulder symptom/complaint
1.2
6.3
724
5988
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
9.2
6.3
12
13
C10AA01
ATC
simvastatin; oral
1.2
6.3
2291
21023
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
1.9
6.3
83
439
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
6.2
6
*
M33
ICD-10 Finland
Dermatopolymyositis
+∞
6.2
6
*
A05AA02
ATC
ursodeoxycholic acid; oral
2.4
6.2
49
207
R03DC01
ATC
zafirlukast; oral
2.1
6.2
65
313
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.8
6.2
107
613
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.4
6.2
252
1785
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
6.2
639
5213
M01AH02
ATC
rofecoxib; oral
1.3
6.2
574
4625
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
7.0
6.2
14
20
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
2.8
6.2
37
134
R06AE09
ATC
levocetirizine; oral
1.3
6.2
427
3308
WX723
NOMESCO Finland
CPAP therapy
1.7
6.2
114
669
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.6
6.2
41
158
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
2.6
6.2
42
165
J92
ICD-10 Finland
Pleural plaque
6.3
6.1
15
24
F2682
NOMESCO Finland
NA
5.7
6.1
16
28
R52.0
ICD-10 Finland
Acute pain
1.8
6.1
95
528
C08CA02
ATC
felodipine; oral
1.3
6.1
467
3670
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.1
6.1
30
96
TPX10
NOMESCO Finland
Implantation of vascular injection port
1.8
6.1
104
596
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
1.9
6.1
83
442
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
4.6
6.1
19
41
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
4.6
6.1
19
41
K74.3
ICD-10 Finland
Primary biliary cirrhosis
3.5
6.1
26
75
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
6.1
576
4659
L03AA02
ATC
filgrastim; parenteral
1.7
6.1
106
615
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
3.7
6.1
24
65
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
6.1
1623
14529
R05CB01
ATC
acetylcysteine; inhalant, oral
1.9
6.0
79
416
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.7
6.0
37
137
I20.09
ICD-10 Finland
Unstable angina
1.4
6.0
285
2080
JN4CD
NOMESCO Finland
Very extensive body CT
1.5
6.0
171
1126
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
6.7
6.0
14
21
R04
ICPC
Breathing problem other
1.7
6.0
123
746
ZYC01
NOMESCO Finland
Remote contact by phone
1.6
6.0
141
886
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.1
6.0
63
304
N06DX01
ATC
memantine; oral
0.7
6.0
166
2395
M54
ICD-10 Finland
Dorsalgia
1.3
6.0
356
2695
L86
ICPC
Back syndrome with radiating pain
1.5
6.0
189
1276
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1668
6438
3.21
322.26
9.1
6.8
kpa
5.0
5.1
0.82
1603
6111
(3027801) Oxygen [Partial pressure] in Arterial blood
1666
6436
3.21
321.27
9.1
6.8
kpa
10.2
12.1
59.23
1604
6105
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
615
1147
5.87
318.02
1.8
1.4
g/l
0.2
0.2
2.94
590
1081
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
787
1826
4.82
317.36
1.8
1.8
u/l
38.4
38.3
0.04
716
1554
(3003396) Base excess in Arterial blood by calculation
1651
6419
3.18
314.06
9.2
6.8
mmol/l
1.4
1.1
2.76
1370
4940
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
618
1188
5.69
309.16
1.8
1.4
g/l
1.2
1.2
1.11
596
1116
(3000492) Spirometry study
1219
3692
3.90
307.65
2.9
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
4099
22521
3.66
307.65
12.7
5.9
%
24.5
26.3
21.54
4006
20688
(3006315) Basophils [#/volume] in Blood
4332
23466
4.15
307.65
11.7
5.4
e9/l
0.0
0.0
5.70
3968
19935
(3001604) Monocytes [#/volume] in Blood
4323
23326
4.16
307.65
11.7
5.4
e9/l
0.7
0.6
21.43
3952
19782
(3006504) Eosinophils/100 leukocytes in Blood
4088
22001
3.77
307.65
12.4
5.7
%
2.7
2.9
4.62
3997
20292
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
562
702
8.74
307.65
1.5
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
685
797
9.59
307.65
1.2
1.2
u/ml
45.6
0.6
—
24
6
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
544
555
10.69
307.65
2.6
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
4094
22110
3.76
307.65
12.9
6.0
%
8.9
8.9
0.01
4005
20453
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
638
1006
6.99
307.65
1.4
1.2
u/ml
41.3
46.7
0.14
35
52
(3015171) Extractable nuclear Ab [Units/volume] in Serum
863
1417
6.96
307.65
1.3
1.2
u/ml
2.0
0.8
1.18
85
133
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
987
1550
7.44
307.65
1.8
1.5
titre
279.5
232.4
0.24
64
76
(44806118)
440
481
9.80
307.65
2.7
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
892
1150
8.95
307.65
2.3
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2177
9135
3.19
307.65
2.8
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
589
735
8.79
307.65
3.0
2.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1990
6703
3.96
307.65
1.4
1.3
iu/ml
57.3
36.5
4.35
698
2029
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1333
1977
8.41
307.65
1.6
1.6
u/ml
16.8
18.4
0.07
30
50
(44790048)
440
481
9.80
307.65
2.7
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
627
945
7.30
307.65
1.4
1.2
u/ml
12.8
6.3
1.23
140
145
(3013650) Neutrophils [#/volume] in Blood by Automated count
4424
27253
3.46
307.65
15.5
8.6
e9/l
4.7
4.3
28.57
4105
23559
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1302
1854
8.72
307.65
3.2
2.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
583
627
10.20
307.65
1.8
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
704
851
9.25
307.65
2.4
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
687
1225
6.21
307.65
2.4
2.2
g/l
128.7
127.5
0.32
269
926
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
616
711
9.55
307.65
1.8
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
2242
5222
6.30
307.65
1.5
1.3
titre
602.8
503.7
1.52
679
1108
(3013115) Eosinophils [#/volume] in Blood
4393
24208
4.15
307.65
12.4
5.6
e9/l
0.2
0.2
2.54
4065
20839
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
598
670
9.82
307.65
2.4
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
329
135
25.74
307.65
2.0
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
1014
2579
4.54
307.65
2.2
1.9
g/l
1.1
1.4
3.38
941
2292
(42870588) Differential panel, method unspecified - Blood
3488
16488
3.71
307.65
11.4
5.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1724
6282
3.46
307.65
2.6
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1838
6295
3.78
307.65
1.3
1.2
u/ml
29.2
13.2
2.68
534
2286
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
781
1284
6.85
307.65
1.7
1.4
iu/ml
11.4
17.2
0.56
33
29
(44790049)
440
481
9.80
307.65
2.7
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
624
933
7.36
307.65
1.4
1.2
u/ml
7.8
3.2
0.75
92
84
(44790047)
440
481
9.80
307.65
2.7
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
749
1139
7.38
307.65
1.9
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
4052
22154
3.62
307.65
12.1
5.6
%
60.5
58.3
23.60
3958
20461
(3022096) Basophils/100 leukocytes in Blood
4056
21411
3.84
307.65
12.3
5.7
%
0.6
0.7
2.88
3973
19770
(3005719) IgG [Mass/volume] in Serum or Plasma
1298
3267
4.81
307.65
4.1
2.6
g/l
10.3
10.5
0.75
1237
2948
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
564
857
7.17
307.65
12.4
4.4
iu/ml
1522.1
2324.4
0.15
132
115
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
742
287
29.41
307.65
2.2
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
552
652
9.23
307.65
1.2
1.1
—
—
—
0
0
(4010399)
1144
3283
4.08
307.65
2.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
611
935
7.17
307.65
1.4
1.2
titre
177.3
154.7
0.07
22
15
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
710
642
12.43
307.65
2.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1728
6258
3.49
307.65
2.6
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
4341
23875
4.06
307.65
11.8
5.5
e9/l
1.9
1.9
0.07
4004
20591
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
879
1097
9.23
307.65
2.4
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
443
166
28.76
307.65
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1046
1114
11.19
307.65
1.9
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
582
776
8.21
307.65
1.3
1.2
u/ml
19.4
2.4
1.82
56
56
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
828
787
12.07
307.65
2.1
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
637
616
11.47
307.65
2.7
2.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1293
3743
4.14
307.65
4.8
4.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
869
2244
4.37
305.53
1.6
1.2
u/ml
254.2
234.5
0.24
809
2034
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
415
537
8.23
302.91
3.5
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1413
5369
3.14
275.60
2.3
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
209
105
20.60
273.94
1.3
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2835
15496
2.59
273.73
6.1
4.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
311
331
9.86
264.41
2.0
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1174
4134
3.29
258.91
5.8
3.9
%
0.8
1.0
1.04
428
1247
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
287
284
10.57
257.11
2.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
286
282
10.61
256.86
2.1
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
539
1117
5.21
246.65
1.8
1.9
mg/l
10.8
12.5
2.05
506
1020
(3002179) Metamyelocytes/100 leukocytes in Blood
1083
3736
3.32
246.12
5.6
3.7
%
0.5
0.7
1.10
336
886
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
149
38
40.20
245.29
3.1
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
323
426
7.96
231.30
2.1
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1040
3648
3.24
228.77
5.9
4.0
%
0.2
0.2
0.04
357
967
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3900
26077
2.45
225.42
10.0
6.1
umol/l
11.4
12.4
5.06
3787
24684
(3039162) Centromere protein B Ab [Units/volume] in Serum
324
442
7.70
225.29
1.3
1.2
u/ml
59.7
51.0
0.18
33
22
(3021440) Promyelocytes/100 leukocytes in Blood
1081
3930
3.14
223.45
5.9
3.9
%
0.1
0.1
1.18
398
1164
(3027135) IgG subclass 1 [Mass/volume] in Serum
298
373
8.36
222.90
1.4
1.3
g/l
7.7
6.7
2.14
204
254
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
395
673
6.22
222.84
5.3
2.3
u/ml
694.4
2666.8
1.11
36
49
(3028192) IgG subclass 2 [Mass/volume] in Serum
297
373
8.33
221.52
1.4
1.3
g/l
3.0
3.0
0.27
207
257
(3024139) IgG subclass 3 [Mass/volume] in Serum
297
373
8.33
221.52
1.4
1.3
g/l
0.5
0.4
2.12
205
257
(4062490)
297
376
8.26
220.05
1.4
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1388
5844
2.80
219.40
10.1
7.0
%
93.7
95.5
16.85
1344
5610
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
889
2903
3.43
219.14
10.8
8.8
mmol/l
24.6
24.3
2.45
819
2686
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
320
451
7.44
216.12
2.0
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
396
701
5.98
214.71
1.4
1.2
u/ml
60.4
45.1
0.83
61
66
(46235355) HIV 1 and 2 tests - Meaningful Use set
1217
4828
2.91
214.71
1.5
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
369
617
6.31
212.00
1.6
1.6
g/l
0.9
0.9
0.06
266
465
(3004616) Nuclear Ab [Presence] in Serum
327
485
7.08
210.80
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
326
482
7.10
210.76
2.0
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3605
23722
2.33
209.37
9.6
6.1
mmol/l
1.2
1.2
4.90
3392
21295
(3018418) pH of Serum or Plasma
2652
15414
2.30
206.49
5.6
4.0
ph
7.4
7.4
1.13
633
2912
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2859
17257
2.27
201.93
4.2
3.2
ng/l
1820.0
1786.7
0.12
2588
15004
(40760892) CBC W Ordered Manual Differential panel - Blood
1860
9395
2.43
198.94
8.9
4.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
433
894
5.15
198.15
4.6
3.6
%
59.6
58.2
1.17
433
894
(3021589) Normoblasts [#/volume] in Blood
3204
20507
2.22
192.86
19.1
10.0
e9/l
0.0
0.0
0.69
2750
16622
(3042936) Bacteria identified in Isolate by Culture
1548
7279
2.53
192.69
2.6
2.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
251
304
8.58
192.65
1.3
1.1
u/ml
29.1
3.1
1.37
19
17
(3013707) Erythrocyte sedimentation rate by Westergren method
4636
34774
2.53
188.48
9.7
4.1
mm/h
18.4
13.9
55.07
4516
31689
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
255
324
8.18
188.14
1.3
1.1
u/ml
66.2
37.1
0.90
24
28
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
253
323
8.14
185.91
1.3
1.1
u/ml
65.8
78.6
—
9
16
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
234
272
8.92
185.55
4.2
3.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
256
334
7.97
184.69
1.3
1.1
u/ml
42.3
76.0
0.59
14
12
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3767
26160
2.21
179.13
10.5
6.8
mmol/l
1.2
1.2
1.50
3151
21930
(3007164) IgA [Mass/volume] in Serum or Plasma
1526
7534
2.38
167.47
1.9
1.5
g/l
2.8
2.6
2.55
1105
4333
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
710
2381
3.25
165.39
2.5
1.8
ug/l
2.3
2.7
0.21
646
2054
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
169
152
11.42
161.19
2.1
1.9
u/ml
61772.4
23010.6
0.26
22
22
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
867
3453
2.77
147.72
5.9
3.8
mmol/l
2.3
1.8
2.96
697
2524
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
348
765
4.77
147.23
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
456
1235
3.92
146.78
5.4
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1804
10013
2.15
145.93
2.4
1.7
mg/l
1.6
1.4
0.89
1485
7772
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
891
3624
2.72
145.60
6.1
3.8
kpa
5.2
5.2
0.10
846
3317
(3011412) CD3 cells [#/volume] in Blood
249
409
6.31
145.12
2.3
2.0
e9/l
1.0
1.1
1.64
176
237
(3009343) pH of Capillary blood
882
3576
2.72
144.99
6.1
3.8
ph
7.4
7.4
4.33
154
438
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
344
762
4.73
144.16
1.3
1.4
u/ml
33.2
14.2
—
6
14
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2355
14491
2.04
143.99
5.4
3.1
u/l
34.2
37.0
0.79
2256
13638
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
317
664
4.99
142.02
1.4
1.4
u/ml
132.2
122.7
0.18
66
139
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
809
3176
2.79
141.34
12.1
6.9
mmol/l
25.1
24.8
0.97
799
3146
(3042733) HLA Ab [Presence] in Serum
130
96
13.82
139.99
4.2
5.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
445
1224
3.85
139.99
1.6
1.6
iu/ml
58.1
5.7
0.91
107
285
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1140
5312
2.42
139.70
11.4
7.4
g/l
123.8
120.2
6.59
1103
5118
(3036481) Cortisol [Moles/volume] in Serum or Plasma
935
4008
2.58
136.87
2.2
2.2
nmol/l
343.0
376.6
4.02
879
3658
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4714
37535
2.25
136.14
14.6
7.6
u/l
78.6
80.9
2.66
4613
35095
(3001964) Herpes simplex virus Ag [Presence] in Specimen
136
117
11.87
133.44
2.9
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
240
413
6.01
133.38
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
240
413
6.01
133.38
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
240
413
6.01
133.38
1.6
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
2018
12026
2.03
132.35
11.0
6.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
154
161
9.79
132.17
3.6
1.7
ug/l
43.5
59.8
1.44
154
154
(3021879) Hepatitis B virus core Ab [Presence] in Serum
671
2467
2.94
132.03
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
903
3878
2.57
131.31
1.6
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1560
8472
2.14
131.27
6.7
3.1
mmol/l
0.8
0.8
1.02
1458
7832
(1175426) CD3 cells/100 lymphocytes in Blood
207
316
6.75
129.45
2.2
2.0
%
71.5
71.1
0.10
200
294
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
204
307
6.85
129.30
2.2
2.0
%
16.2
13.9
0.89
81
127
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
213
340
6.46
127.59
1.4
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2250
14074
1.97
127.32
4.7
3.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
182
254
7.36
123.57
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
182
254
7.36
123.57
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
182
254
7.36
123.57
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
197
300
6.76
123.45
2.3
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2468
16066
1.92
122.80
5.0
3.5
e6/l
95.0
108.5
0.10
2021
12584
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
182
257
7.27
122.28
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
182
257
7.27
122.28
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
182
257
7.27
122.28
1.2
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
412
1188
3.65
120.63
3.5
2.5
%
15.8
16.0
0.31
223
628
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
934
4232
2.43
120.33
1.5
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3179
22560
1.88
120.11
6.4
4.8
g/l
33.3
34.7
33.71
2969
20785
(3027315) Oxygen [Partial pressure] in Blood
421
1236
3.59
119.96
7.2
4.3
kpa
8.2
8.4
1.40
412
1205
(3024471) HLA-A [Type]
121
105
11.74
118.02
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2288
14670
1.91
117.97
4.8
3.3
e6/l
0.4
0.5
0.82
1830
11259
(3024932) HLA-DR beta [Type]
119
101
12.00
117.73
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3156
22456
1.87
117.08
12.7
11.0
inr
1.3
1.3
3.68
1064
6102
(3012501) Base excess in Blood by calculation
415
1230
3.55
116.49
7.2
4.3
mmol/l
2.8
2.7
0.32
319
832
(3013290) Carbon dioxide [Partial pressure] in Blood
415
1231
3.55
116.35
7.2
4.3
kpa
5.0
5.0
0.35
406
1201
(3018095) Leukocytes [#/volume] in Urine
2679
18158
1.87
115.46
5.9
3.9
e6/l
101.7
110.9
0.15
2087
13372
(3015235) Bicarbonate [Moles/volume] in Capillary blood
466
1502
3.28
114.53
4.9
3.1
mmol/l
25.3
24.9
1.20
428
1293
(3010421) pH of Blood
449
1432
3.31
112.22
7.0
4.1
ph
7.4
7.4
1.07
406
1203
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
420
1285
3.44
112.16
3.3
2.3
g/l
3.8
3.6
2.28
408
1218
(3021901) Oxygen saturation in Capillary blood
380
1094
3.64
111.37
4.5
2.7
—
—
—
0
0
(3026782) Osmolality of Urine
1776
10629
1.96
111.22
4.0
2.9
mosm/kgh2o
533.0
554.7
4.86
1594
9029
(3008152) Bicarbonate [Moles/volume] in Arterial blood
816
3602
2.47
110.72
8.7
6.6
mmol/l
25.1
24.5
4.37
778
3357
(3000850) Epithelial cells [#/volume] in Urine
1869
11415
1.93
109.95
3.9
2.7
e6/l
4.6
4.6
0.06
1700
10002
(21494815) CD4 cells/100 lymphocytes in Specimen
198
344
5.92
108.85
2.3
2.0
%
32.5
41.3
1.12
14
43
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1048
5201
2.23
108.33
4.2
3.0
ng/l
239.4
240.5
0.03
986
4774
(3028626) Oxygen [Partial pressure] in Capillary blood
426
1347
3.33
107.87
5.7
3.2
kpa
7.7
8.0
2.33
407
1241
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
146
185
8.07
107.71
1.5
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1032
5126
2.23
106.27
11.5
6.7
mmol/l
10.7
11.0
0.64
984
4839
(3013826) Glucose [Moles/volume] in Serum or Plasma
3875
29911
1.85
105.57
8.7
4.8
mmol/l
6.8
6.9
0.58
3731
28144
(3023420) DNA double strand Ab [Units/volume] in Serum
201
370
5.59
103.93
1.9
1.2
iu/ml
22.3
24.9
—
10
16
(3010375) cycloSPORINE [Mass/volume] in Blood
140
177
8.08
103.47
44.3
23.1
ug/l
156.4
109.0
7.28
115
144
(40757373) Influenza virus identified in Isolate
112
108
10.55
101.76
2.9
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1328
7513
1.99
95.74
2.9
2.6
%
20.7
21.9
2.66
1127
6324
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1194
6506
2.05
95.66
4.5
4.0
u/l
269.4
246.2
4.81
1131
6112
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
238
548
4.48
94.71
1.3
1.2
u/ml
4.4
3.7
0.12
96
164
(3022948) Iron [Moles/volume] in Serum or Plasma
1462
8575
1.94
94.69
2.9
2.5
umol/l
11.5
12.3
5.04
1381
7873
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
391
1270
3.23
94.52
3.4
2.2
%
89.6
88.4
0.50
375
1205
(3009871) Measles virus Ab [Titer] in Serum
96
83
11.74
93.80
1.3
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
439
1538
3.00
93.19
1.7
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1378
7978
1.95
92.46
2.8
2.5
g/l
2.2
2.3
0.55
1285
7336
(3000991) Gas panel - Venous blood
917
4596
2.18
91.21
12.2
7.8
—
—
—
0
0
(4306422)
223
503
4.57
91.05
1.3
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2697
19241
1.74
90.41
2.8
2.2
nmol/l
77.8
79.0
1.29
2480
16830
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
219
492
4.58
89.86
1.2
1.1
%
118.7
114.4
0.92
211
434
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
118
146
8.23
88.76
2.2
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
187
372
5.16
88.68
1.4
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1229
6950
1.97
87.79
11.8
6.7
mmol/l
103.8
104.4
4.11
1194
6788
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
226
534
4.36
86.97
1.3
1.2
u/ml
3.4
4.9
1.05
135
232
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
251
645
4.02
86.36
1.2
1.2
u/ml
344.1
288.6
1.14
164
380
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
153
259
6.04
86.34
1.5
1.3
u/ml
1.5
1.4
0.03
95
130
(3028433) Virus identified in Specimen by Culture
117
149
7.99
85.92
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
174
334
5.34
85.89
2.2
2.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
114
141
8.22
85.78
41.3
31.9
ug/l
8.1
7.3
2.13
103
126
(3013293) Extractable nuclear Ab [Presence] in Serum
73
46
16.06
85.55
1.5
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
938
4856
2.11
85.38
11.0
6.5
mmol/l
1.5
1.4
1.22
891
4655
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
170
323
5.39
84.87
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
806
3942
2.21
84.82
1.9
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
170
325
5.36
84.30
1.3
1.2
titre
112.7
130.0
0.20
11
12
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
170
325
5.36
84.30
1.3
1.2
titre
128.0
131.8
0.03
35
55
(3004588) Protein electrophoresis panel - Serum or Plasma
821
4057
2.19
84.16
2.1
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
4106
33284
1.76
83.64
6.8
4.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
597
2582
2.46
83.55
6.4
4.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
295
871
3.51
82.91
2.4
1.9
mmol/l
1.7
1.7
0.54
289
848
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
259
702
3.81
82.66
1.2
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
933
4876
2.08
82.60
2.2
2.5
g/l
66.2
66.0
0.22
864
4358
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
354
1173
3.15
82.59
3.6
2.4
%
210.2
203.6
0.64
337
1121
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
128
192
6.79
81.29
1.7
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
128
192
6.79
81.29
1.7
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
147
254
5.91
81.22
1.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
147
254
5.91
81.22
1.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
147
254
5.91
81.22
1.7
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
155
282
5.62
81.12
2.2
2.0
e6/l
471.2
526.2
0.49
128
233
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
128
193
6.76
80.90
1.7
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1218
7037
1.92
80.88
7.9
5.6
mmol/l
1.1
1.0
0.78
1133
6478
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
659
3032
2.32
80.08
14.8
9.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
119
170
7.12
79.05
2.1
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
145
254
5.83
78.98
1.7
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
350
1191
3.06
77.95
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
350
1191
3.06
77.95
1.5
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
210
514
4.20
77.13
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
165
334
5.05
76.68
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
297
926
3.32
76.56
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
177
382
4.75
76.26
1.2
1.2
%
96.5
94.3
0.45
172
357
(3036489) Thrombin time
426
1635
2.73
76.02
3.3
1.9
s
21.7
21.8
0.03
389
1473
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2276
16061
1.68
75.19
3.5
2.2
u/l
154.6
228.0
4.61
2149
14947
(3033658) Prothrombin time (PT) actual/Normal
1863
12499
1.72
74.13
6.4
4.0
%
84.4
84.8
0.33
1828
12203
(3026493) Urate [Moles/volume] in Serum or Plasma
1959
13360
1.70
73.15
4.9
2.8
umol/l
2219.4
5520.8
4.75
1724
11332
(3002032) Base excess in Venous blood by calculation
959
5277
1.98
72.80
4.9
3.7
mmol/l
2.3
1.9
2.05
797
4235
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
143
269
5.42
72.18
2.3
2.1
e9/l
0.2
0.2
0.11
126
233
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1626
10575
1.74
71.99
5.4
4.1
ng/l
425.2
487.2
0.24
1444
8990
(4268621)
165
355
4.75
71.35
2.3
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
84
89
9.56
71.30
1.6
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
956
5293
1.96
71.15
4.9
3.7
kpa
5.9
5.8
1.20
917
5126
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
890
4822
2.00
70.46
2.3
2.2
g/l
0.2
0.2
1.63
831
4454
(4015189)
102
140
7.40
70.23
2.1
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
171
385
4.54
69.93
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
3017
23138
1.62
69.81
4.9
3.9
estimate
0.0
0.0
0.50
831
4274
(3012544) pH of Venous blood
976
5481
1.93
69.52
4.8
3.7
ph
7.4
7.4
—
8
31
(3017569) Oxygen content in Arterial blood
144
282
5.21
69.50
2.2
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
704
3518
2.14
69.35
2.0
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1152
6844
1.85
68.87
3.5
2.4
%
1.9
1.8
5.62
1020
5999
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
659
3244
2.16
67.38
1.7
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
3002
23139
1.60
66.91
6.7
5.3
estimate
0.0
0.0
0.50
839
4307
(3015377) Calcium [Moles/volume] in Serum or Plasma
2381
17380
1.62
66.43
4.3
3.4
mmol/l
2.3
2.3
3.16
2137
14849
(3009261) Glucose [Presence] in Urine by Test strip
3029
23465
1.60
65.56
5.0
4.0
estimate
0.0
0.0
1.60
816
4185
(3014007) Fractional oxyhemoglobin in Arterial blood
693
3532
2.09
64.58
14.2
8.5
%
92.3
93.9
9.88
687
3516
(3031040) Bacteria [#/volume] in Urine by Automated count
3943
32589
1.63
64.53
6.4
4.9
e6/l
744.1
1763.5
1.39
64
562
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
810
4386
1.98
63.78
5.0
3.9
mmol/l
1.2
1.2
2.87
739
3816
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
551
2628
2.21
60.74
4.9
3.8
mmol/l
24.4
24.1
1.48
496
2352
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
127
251
5.15
60.67
2.1
1.5
u/l
6.0
6.7
0.42
112
213
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
172
438
4.01
59.87
1.1
1.1
iu/ml
1.8
2.3
—
9
12
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
119
225
5.38
59.74
1.1
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1311
8429
1.71
58.61
2.8
2.0
s
30.0
30.2
0.52
1281
8161
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
674
3521
2.03
58.44
14.4
8.5
%
0.6
0.7
0.97
666
3492
(3034426) Prothrombin time (PT)
85
118
7.29
57.94
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1309
8442
1.71
57.75
4.2
3.2
e6/l
1.6
1.9
0.89
742
4794
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
672
3536
2.02
57.04
14.4
8.3
%
1.4
1.3
1.92
664
3512
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
459
2093
2.29
56.27
3.9
2.8
u/ml
0.3
0.3
0.80
281
1184
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
64
65
9.94
56.00
1.3
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
738
4042
1.94
55.74
5.3
4.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2663
20536
1.54
55.17
5.3
4.1
ng/l
104.5
79.5
0.15
2137
15682
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
120
247
4.94
54.71
2.5
2.6
%
39.1
35.9
0.73
54
89
(3023520) Reticulocytes [#/volume] in Blood
888
5202
1.83
54.34
3.4
2.5
e9/l
73.3
67.7
3.52
623
3976
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
73
93
7.93
53.59
1.1
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2499
19090
1.53
53.55
3.4
2.9
ug/l
201.8
155.9
7.38
2294
17284
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
74
98
7.63
52.57
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
136
324
4.27
51.77
2.6
2.4
ph
7.4
7.4
0.48
83
106
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
88
143
6.23
51.76
2.2
2.0
%
30.4
30.1
0.06
83
130
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1901
13767
1.56
51.33
2.6
2.3
mg/l
3.3
3.1
2.74
1673
11620
(3006245) CD3-CD19+ cells/100 cells in Blood
87
142
6.20
50.95
2.2
2.0
%
9.6
12.4
0.82
80
125
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
188
568
3.39
50.88
1.1
1.1
g/l
1.6
1.5
0.07
166
506
(3002385) Erythrocyte distribution width [Ratio]
4246
36602
1.56
50.06
38.1
20.4
%
14.3
13.9
62.82
4209
35700
(3020891) Body temperature
467
2248
2.17
50.01
5.8
4.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
127
295
4.38
49.96
2.4
2.0
e6/l
634.8
602.5
0.17
57
127
(4035726)
763
4392
1.85
49.07
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
915
5589
1.75
48.15
5.0
3.7
—
—
—
0
0
(3015736) pH of Urine
2370
18192
1.50
47.98
4.2
3.7
—
5.8
—
0
18
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1333
9030
1.61
47.21
3.9
3.0
e6/l
1.0
1.2
1.23
769
5340
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
52
51
10.28
46.62
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
475
2367
2.09
46.42
6.0
4.9
%
1.8
1.6
3.88
448
2218
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
246
924
2.73
45.52
1.4
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
448
2217
2.10
44.55
7.3
4.3
mmol/l
25.1
24.8
1.33
426
2017
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
889
5497
1.73
44.51
3.1
2.7
umol/l
10.5
9.3
0.62
776
4793
(3047181) Lactate [Moles/volume] in Blood
373
1719
2.25
44.38
8.4
5.9
mmol/l
1.4
1.3
0.70
343
1520
(3024354) Oxygen [Partial pressure] in Venous blood
739
4339
1.80
44.26
3.8
3.1
kpa
4.5
4.5
0.03
705
4186
(3004809) Band form neutrophils/100 leukocytes in Blood
245
944
2.66
43.13
4.1
3.6
%
1.5
1.5
0.01
214
700
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
95
199
4.84
42.47
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
268
1089
2.53
42.32
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2835
22931
1.45
42.08
3.0
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
236
907
2.67
41.75
1.1
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
37
25
14.89
41.64
1.1
1.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
398
1940
2.13
41.11
3.5
2.2
ug/l
387.3
640.8
1.19
377
1838
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
523
2814
1.94
41.08
1.9
1.7
g/l
1.6
1.6
0.74
439
2393
(3037756) Immunofixation for Serum or Plasma
299
1297
2.37
40.95
1.5
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
397
1939
2.12
40.79
2.5
3.2
mg/l
62.0
92.6
0.52
287
1605
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
396
1935
2.12
40.63
2.5
3.2
mg/l
43.4
54.4
0.73
285
1602
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
89
186
4.84
39.92
1.2
1.2
ratio
1.1
1.1
0.09
34
61
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
386
1891
2.11
39.32
2.5
3.2
ratio
4.1
3.5
0.11
25
147
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
253
1036
2.51
39.30
1.9
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1635
12018
1.50
38.88
5.0
3.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
230
914
2.58
38.04
1.7
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
75
142
5.34
37.66
1.1
1.1
u/ml
27.9
6.6
—
10
14
(3052851) Hemolysis interference index of Serum or Plasma
340
1612
2.18
37.65
4.4
3.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
353
1707
2.14
37.17
2.4
2.2
g/l
0.1
0.1
0.10
327
1543
(3018405) Lactate [Moles/volume] in Arterial blood
402
2042
2.04
37.13
4.7
3.8
mmol/l
1.4
1.4
0.24
396
2008
(3007930) Methemoglobin/Hemoglobin.total in Blood
443
2338
1.97
36.72
6.4
5.0
%
0.9
0.9
0.24
415
2195
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
150
484
3.15
36.52
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
332
1582
2.16
36.29
2.4
2.2
g/l
0.0
0.0
1.04
306
1423
(3029937) Albumin [Presence] in Urine by Test strip
1708
12807
1.47
36.26
5.4
4.4
estimate
0.0
0.0
0.88
779
4073
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
327
1552
2.17
36.10
2.4
2.2
g/l
0.0
0.0
0.00
306
1417
(3007853) Bacteria identified in Skin by Aerobe culture
899
5868
1.63
35.98
2.2
1.8
—
—
—
0
0
(3039000) Anion gap in Blood
279
1245
2.30
35.78
8.4
6.7
mmol/l
11.7
11.2
1.85
256
1112
(3018572) Chloride [Moles/volume] in Blood
279
1245
2.30
35.78
8.4
6.7
mmol/l
103.8
105.2
4.95
256
1112
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
413
2148
1.99
35.68
2.4
2.3
g/l
3.3
3.1
4.15
334
1660
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
414
2162
1.98
35.35
2.4
2.3
g/l
10.6
10.2
0.79
353
1800
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
436
2319
1.95
35.30
2.3
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
436
2321
1.95
35.21
2.3
2.3
g/l
7.9
7.4
4.43
338
1684
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
435
2315
1.95
35.15
2.3
2.3
g/l
3.9
3.8
0.35
330
1622
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2020
15726
1.43
34.77
3.0
2.6
u/l
61.5
58.9
0.39
1885
14446
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
380
1954
2.01
33.88
2.4
2.3
g/l
0.7
1.0
0.97
337
1649
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
236
1007
2.40
33.52
1.3
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2035
15957
1.42
33.28
3.8
3.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5003
45981
1.57
33.17
34.8
16.8
mg/l
25.3
26.9
3.37
4687
37492
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
352
1788
2.03
32.45
2.4
2.1
g/l
35.9
37.4
4.58
319
1497
(3029075) Extractable nuclear Ab panel - Serum
57
97
5.92
32.07
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
3840
33657
1.40
31.78
5.8
4.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
141
477
3.00
31.69
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
299
1452
2.12
31.10
2.4
3.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
962
6647
1.53
29.61
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
55
98
5.66
29.52
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
245
1124
2.23
29.41
1.2
1.2
titre
107.1
93.9
0.22
28
71
(3034770) Mitochondria Ab [Titer] in Serum
244
1129
2.21
28.69
1.2
1.2
titre
977.5
966.3
0.01
12
35
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1343
9992
1.44
28.47
3.0
3.1
mmol/l
2.5
2.5
8.49
1192
8702
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
323
1691
1.96
27.31
1.4
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
164
653
2.55
27.07
1.1
1.3
miu/ml
195.3
206.7
0.11
23
239
(3011397) Hemoglobin [Presence] in Urine by Test strip
1469
11221
1.41
26.63
4.3
3.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
282
1432
2.02
26.00
1.6
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3222
27932
1.34
25.62
4.4
3.1
u/l
66.1
55.0
5.17
2995
25360
(3004119) Hemoglobin [Mass/volume] in Venous blood
550
3440
1.66
25.60
4.7
3.3
g/l
125.8
127.6
1.12
531
3351
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2167
17721
1.35
25.56
5.3
4.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
50
94
5.36
25.37
2.3
1.9
e6/l
958.8
1629.0
0.21
25
40
(3043409) Potassium [Moles/volume] in Arterial blood
321
1722
1.91
25.24
5.4
4.1
mmol/l
4.0
3.9
2.57
293
1601
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1147
8475
1.44
24.78
1.3
1.2
u/ml
1.1
1.7
3.19
291
2093
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
50
97
5.19
24.51
1.1
1.1
%
89.0
83.1
0.56
32
52
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
115
403
2.89
24.35
1.8
1.8
mg/l
4.5
4.6
0.06
107
385
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
63
150
4.23
24.14
1.3
2.1
%
197.5
168.2
1.15
57
140
(3036782) Glucose [Moles/volume] in Pleural fluid
150
609
2.50
23.81
1.5
1.4
mmol/l
6.6
6.4
0.26
136
561
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
58
132
4.43
23.55
2.4
2.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
97
315
3.11
23.48
5.8
3.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
52
109
4.80
23.34
1.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
249
1260
2.02
23.19
3.5
3.0
mg/l
1.8
1.7
0.70
230
1120
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
156
657
2.41
22.89
1.2
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
148
612
2.45
22.61
1.7
1.5
%
59.1
62.3
0.44
89
403
(3008757) Leukocyte morphology finding [Identifier] in Blood
148
613
2.45
22.53
4.9
4.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
398
2361
1.74
22.49
1.4
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
49
101
4.88
22.44
1.1
1.3
%
89.7
81.6
0.69
34
57
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
29
9
32.37
22.37
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
667
4507
1.54
22.32
2.7
2.4
u/l
36.2
48.1
0.57
605
3836
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
123
469
2.66
22.22
1.9
1.4
%
39.1
26.2
3.10
72
300
(3027273) Bicarbonate [Moles/volume] in Venous blood
455
2823
1.66
21.76
4.6
3.4
mmol/l
25.6
25.1
2.04
430
2736
(3003327) Ova and parasites identified in Stool by Light microscopy
235
1198
2.00
21.45
1.9
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
48
104
4.64
20.74
1.6
1.4
ug/l
8.2
9.4
0.93
48
104
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
118
458
2.61
20.61
1.7
1.5
u/l
14.2
13.3
0.71
113
438
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
262
1408
1.90
20.50
1.6
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
605
4074
1.54
20.49
1.7
1.7
%
1.7
1.6
2.05
509
3437
(3045142) Bone marrow Pathology biopsy report
143
611
2.37
20.36
1.5
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
240
1260
1.94
20.15
1.8
1.6
e6/l
13794.1
14685.3
0.09
182
911
(3023183) Ammonium ion [Moles/volume] in Plasma
218
1114
1.99
19.79
2.7
2.5
umol/l
33.3
34.8
0.35
192
925
(3045716) Anion gap in Serum or Plasma
80
257
3.14
19.78
2.1
2.2
mmol/l
8.5
9.4
1.33
63
204
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
393
2408
1.68
19.70
2.7
1.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
74
228
3.27
19.60
1.7
1.4
%
3.8
4.0
0.05
20
58
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
42
86
4.91
19.41
1.5
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
38
72
5.31
19.16
1.2
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1432
11391
1.34
19.08
1.9
1.8
nmol/l
1187.6
1162.3
0.43
1086
8496
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
120
488
2.49
19.06
1.3
1.3
u/l
14.8
13.4
0.24
108
446
(3004451) EKG impression Narrative
86
295
2.94
19.01
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
198
997
2.02
18.75
1.8
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
142
632
2.28
18.44
1.4
1.3
u/l
482.0
379.2
0.60
131
596
(3012441) Differential panel - Pleural fluid
152
696
2.22
18.44
1.6
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
183
914
2.03
17.74
1.5
1.5
g/l
32.6
31.3
0.62
158
816
(3044941) Cell count panel - Synovial fluid
168
813
2.10
17.73
1.8
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
161
767
2.13
17.70
1.2
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
469
3084
1.57
17.60
3.3
3.3
e9/l
4.6
4.2
1.98
374
2212
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
156
737
2.15
17.52
8.1
6.2
mg/l
12.0
12.1
0.12
145
678
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
78
266
2.96
17.45
4.0
3.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
406
2586
1.61
17.45
3.9
2.7
%
0.7
0.7
0.78
398
2475
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
36
71
5.10
17.38
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2226
18985
1.28
17.26
2.4
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1594
13033
1.31
17.15
1.8
1.6
nmol/l
18.9
20.1
2.37
1423
11031
(3044242) Glucose [Moles/volume] in Arterial blood
86
313
2.77
17.09
1.7
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
171
845
2.05
17.08
2.9
3.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
137
621
2.23
17.06
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
40
88
4.57
17.01
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
130
592
2.22
16.03
1.5
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
121
536
2.28
15.94
1.3
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
638
4586
1.44
15.47
2.3
2.1
ug/g
194.6
164.0
0.99
522
3553
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
22
30
7.36
15.24
1.1
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
112
491
2.31
15.14
1.1
1.2
u/l
56.8
63.8
0.60
90
323
(3045788) Cell count panel - Pleural fluid
131
613
2.16
15.13
1.6
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
206
1132
1.85
15.11
3.9
2.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
144
701
2.08
15.02
1.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
275
1651
1.70
14.90
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
123
567
2.19
14.76
5.4
3.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
85
333
2.58
14.68
1.4
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
60
195
3.10
14.65
4.1
3.8
%
60.6
54.4
1.33
60
188
(40768795) Lymph node Pathology biopsy report
106
463
2.31
14.47
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
250
1478
1.72
14.34
1.4
1.4
ug/g
290.2
264.5
0.44
156
892
(40768446) Kidney Pathology biopsy report
52
157
3.33
14.32
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
570
4078
1.44
14.14
4.3
3.8
ng/l
104.9
96.7
0.85
495
3439
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
557
3990
1.44
13.72
3.8
2.8
ml/min/173m2
56.7
61.0
1.99
268
1691
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
35
83
4.24
13.59
1.7
1.8
mg/l
6.2
9.0
2.03
29
69
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
342
2227
1.57
13.39
2.3
1.8
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
32
72
4.46
13.28
1.3
1.2
ng/l
120.2
1235.0
0.49
21
48
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3691
33952
1.23
12.88
4.1
3.8
pmol/l
15.0
15.0
0.25
3333
30204
(21494567) Legionella sp IgM Ab [Presence] in Serum
20
30
6.69
12.73
1.2
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
20
30
6.69
12.73
1.2
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
147
772
1.93
12.46
1.6
1.9
ug/l
23.1
24.6
0.12
142
754
(3050794) Legionella sp Ab [Presence] in Serum
23
41
5.63
12.40
1.1
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
29
65
4.48
12.11
1.0
1.2
%
93.4
76.0
—
10
23
(3044927) Protein electrophoresis panel - Urine
124
627
2.00
11.75
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
226
1374
1.67
11.74
3.0
3.1
nmol/l
0.9
0.8
0.38
176
1033
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2552
22751
1.21
11.67
5.2
4.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
15
9.35
11.65
1.4
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
130
671
1.96
11.62
15.0
18.7
mmol/l
7.5
7.5
0.09
114
552
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
23
44
5.24
11.52
1.0
1.0
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
0.8
0.9
—
7
11
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
2.8
0.6
—
8
11
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
1.3
1.3
—
6
12
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
1.5
3.5
—
9
12
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
3.4
2.7
—
7
11
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
5.2
2.2
—
6
10
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
2.2
3.3
—
6
10
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
6.2
1.2
—
5
12
(3010726) Horse dander IgE Ab [Units/volume] in Serum
77
325
2.39
11.45
1.1
1.1
u/ml
2.6
1.5
0.38
29
85
(3023430) Cat dander IgE Ab [Units/volume] in Serum
65
254
2.58
11.38
1.0
1.1
u/ml
1.6
3.3
0.84
34
102
(3023199) Leukocytes [#/volume] in Pleural fluid
148
804
1.86
11.35
1.6
1.5
e6/l
4879.0
1826.8
0.62
100
585
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
78
333
2.36
11.31
1.4
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
69
279
2.49
11.26
1.4
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
69
279
2.49
11.26
1.4
1.4
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
28
65
4.32
11.21
1.1
1.2
%
77.0
81.6
—
9
22
(3028308) Erythrocytes [#/volume] in Pleural fluid
136
723
1.90
11.16
1.6
1.5
e6/l
128625.3
60329.2
0.95
78
429
(3014133) Dog dander IgE Ab [Units/volume] in Serum
68
275
2.49
11.10
1.0
1.1
u/ml
3.5
2.6
0.23
34
112
(3000012) Reticulocyte production index
75
318
2.38
11.05
2.0
1.5
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
15
19
7.91
11.00
1.6
1.3
mg/l
0.2
2.2
—
5
13
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
94
441
2.15
10.90
1.1
1.1
u/ml
1.5
2.4
0.41
48
179
(3035880) pH of Pleural fluid
83
371
2.25
10.84
1.3
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
682
5260
1.34
10.65
2.6
2.4
ug/l
10.9
6.8
4.18
597
4527
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
72
305
2.38
10.65
1.2
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
45
150
3.02
10.62
1.1
1.1
u/ml
14.3
2.3
1.08
11
20
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1371
11559
1.24
10.57
1.8
1.7
pmol/l
39405345.0
26461899.3
0.27
1109
9357
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
193
1158
1.69
10.57
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1880
16386
1.22
10.51
3.6
3.2
mmol/l
7.1
7.4
1.83
1559
13468
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
68
284
2.41
10.39
1.1
1.2
u/l
95.8
92.0
0.12
62
241
(3017354) Segmented neutrophils/100 leukocytes in Blood
114
587
1.96
10.31
4.6
3.5
%
54.5
59.3
1.35
83
352
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
66
273
2.43
10.30
1.1
1.2
u/l
44.2
24.8
1.26
60
227
(3003888) Timothy IgE Ab [Units/volume] in Serum
84
386
2.19
10.29
1.1
1.1
u/ml
3.9
3.8
0.03
48
185
(3022493) Free Hemoglobin [Mass/volume] in Plasma
57
221
2.59
10.18
5.9
4.5
mg/l
61.9
68.9
0.43
45
149
(44806071)
21
42
5.01
10.03
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1836
16038
1.21
9.90
3.6
3.2
mg/l
682.9
321.1
1.98
1234
10282
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
123
660
1.88
9.86
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
325
2246
1.47
9.68
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
136
758
1.81
9.67
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
45
159
2.84
9.61
1.1
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
11
10.02
9.54
1.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2459
22129
1.19
9.46
2.2
2.1
pmol/l
91.3
93.1
1.06
1336
11627
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
54
4.27
9.11
1.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
19
38
5.01
9.08
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
641
5013
1.31
9.04
1.4
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
55
223
2.48
9.00
1.0
1.0
u/ml
0.2
0.3
0.18
23
72
(3044640) Blood type and Crossmatch panel - Blood
1816
15977
1.20
8.85
3.2
2.6
—
—
—
0
0
(3017704) Immunofixation for Urine
73
338
2.17
8.83
1.3
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
48
184
2.62
8.82
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4887
46917
1.24
8.64
27.3
16.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4209
39861
1.19
8.40
34.0
18.2
%
38.8
38.8
0.17
2670
25242
(3022145) Colonoscopy Study observation
663
5261
1.29
8.37
1.3
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
39
138
2.84
8.35
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
92
476
1.95
8.29
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1909
16960
1.19
8.18
4.5
4.0
mg/mmol
12.8
9.6
1.60
1240
10766
(3008401) Mugwort IgE Ab [Units/volume] in Serum
77
376
2.06
8.16
1.1
1.1
u/ml
0.5
1.4
1.35
37
162
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
516
6625
0.76
8.15
9.8
8.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
11
14
7.87
7.98
1.8
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
65
300
2.18
7.97
1.4
1.6
u/l
8.9
6.1
0.68
37
138
(36660697) Celiac disease serology panel - Serum
411
3071
1.36
7.90
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
55
238
2.32
7.86
1.1
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
46
184
2.51
7.80
5.7
6.6
mmol/l
24.5
24.6
0.04
39
165
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
55
239
2.31
7.79
1.1
1.0
—
—
—
0
0
(3036603) Volume of Urine
68
325
2.10
7.65
1.4
1.7
ml
1834.5
1813.8
0.04
19
86
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
10
12
8.35
7.58
1.1
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
49
207
2.38
7.41
1.3
1.3
mmol/l
3.7
3.5
0.14
43
185
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
20
50
4.01
7.33
1.7
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
56
252
2.23
7.33
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5004
48334
1.23
7.33
35.7
20.1
mmol/l
139.0
139.6
47.45
4943
47029
(3022217) INR in Platelet poor plasma by Coagulation assay
970
8164
1.22
7.33
29.9
29.5
inr
1.5
1.5
0.04
102
1146
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
76
386
1.98
7.28
1.6
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
69
3.49
7.25
1.4
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
720
5882
1.26
7.15
3.2
4.0
ug/l
14.2
23.6
1.16
594
4877
(3011325) HIV 1+2 Ab [Presence] in Serum
10
13
7.70
7.12
1.1
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
76
391
1.96
7.03
1.6
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
153
967
1.60
6.97
1.4
1.3
mmol/l
66.0
62.6
0.49
138
775
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
100
565
1.78
6.92
2.6
3.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5006
48425
1.22
6.82
36.0
20.2
mmol/l
4.0
4.0
3.32
4938
47052
(3001893) Eosinophils/100 leukocytes in Pleural fluid
49
216
2.28
6.76
1.4
1.4
%
1.4
2.5
0.78
36
182
(3014765) Yersinia sp identified in Stool by Organism specific culture
192
1289
1.51
6.70
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
193
1298
1.50
6.68
1.3
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
30
106
2.84
6.51
1.3
1.5
%
4.0
6.0
0.57
16
50
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
59
286
2.07
6.46
1.7
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
59
286
2.07
6.46
1.7
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
34
131
2.60
6.28
6.4
7.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
379
2900
1.33
6.27
2.6
2.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
188
1278
1.49
6.20
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
311
2316
1.36
6.17
2.6
3.3
pmol/l
4.2
4.4
1.72
267
2013
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1385
12216
1.17
6.16
3.1
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
68
354
1.93
6.13
1.1
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
33
127
2.61
6.12
5.2
2.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4345
41643
1.16
6.01
5.1
4.7
mu/l
2.1
2.1
0.09
3964
37264
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
45
202
2.24
5.99
1.1
1.1
iu/ml
7.6
13.4
—
6
49
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
515
6366
0.79
5.97
4.7
4.8
%
32.4
33.1
0.70
377
4136
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
20
59
3.40
5.85
1.3
1.0
iu/ml
6.3
6.8
0.07
12
24
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
27
96
2.82
5.82
1.3
1.3
—
—
—
0
0
(44813793)
50
238
2.11
5.78
1.1
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
32
125
2.57
5.77
1.2
1.2
mmol/l
2.0
1.6
1.10
15
81
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
21
65
3.24
5.71
1.5
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
163
1096
1.50
5.71
1.6
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
54
267
2.03
5.66
1.4
1.4
%
60.3
69.0
0.79
36
217
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
176
2.28
5.60
3.3
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
176
2.28
5.60
3.4
2.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
57
289
1.98
5.58
2.4
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
84
484
1.75
5.52
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
85
493
1.73
5.47
1.3
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
41
185
2.22
5.43
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
140
923
1.53
5.40
1.2
1.3
u/l
45.5
38.5
0.17
123
800
(3024263) Appearance of Synovial fluid
58
301
1.94
5.33
2.0
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4989
48474
1.18
5.27
20.7
11.0
u/l
24.8
25.6
2.55
4922
46339
(3019768) Coxiella burnetii Ab [Presence] in Serum
12
26
4.62
5.25
1.4
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
148
994
1.50
5.24
1.1
1.1
u/ml
19.8
8.5
0.66
11
78
(3037121) Protein [Mass/volume] in Urine
249
1847
1.36
5.12
2.8
3.0
g/l
0.4
0.3
0.78
126
777
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
30
121
2.49
5.11
1.7
1.5
ug/l
0.3
0.4
0.53
23
66
(21494755) Public health laboratory ask at order entry panel
137
2018
0.67
5.07
1.3
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
49
245
2.01
5.02
1.2
1.1
u/l
94.4
93.0
0.03
41
181
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
49
245
2.01
5.02
1.2
1.1
u/l
33.4
35.6
0.07
40
176
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
104
652
1.61
5.02
1.6
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
59
315
1.88
5.00
1.0
1.0
mg/l
293.8
285.6
0.40
54
277
(3044416) Complement C4 [Mass/volume] in Pleural fluid
14
36
3.90
4.98
1.1
1.1
g/l
0.1
0.1
—
7
28
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4470
43140
1.15
4.85
6.9
6.5
mmol/mol
41.5
40.8
4.00
4136
39203
(3024522) Salmonella sp identified in Specimen by Organism specific culture
104
658
1.59
4.84
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
103
651
1.59
4.82
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
103
651
1.59
4.82
1.6
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
65
363
1.80
4.80
2.1
2.2
mmol/l
7.5
6.8
1.05
53
238
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
165
2321
0.70
4.77
1.9
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
103
653
1.59
4.76
1.6
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
17
52
3.28
4.74
2.4
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4458
43050
1.14
4.67
29.3
16.1
ml/min/173m2
73.4
74.2
1.54
4026
35700
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
14
38
3.69
4.64
1.3
1.3
ml/s/173m2
0.8
0.8
—
8
25
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
30
127
2.37
4.64
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
104
667
1.57
4.59
1.6
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
58
318
1.83
4.56
2.2
2.0
min
476.0
493.3
0.52
37
220
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
19
64
2.98
4.55
1.3
1.3
nmol/l
12.0
146303.6
0.49
14
54
(3013512) EKG study
1699
15502
1.13
4.51
5.2
4.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
46
235
1.96
4.48
1.5
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
27
112
2.42
4.37
6.2
7.8
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
24
94
2.56
4.37
1.3
1.3
%
18.8
21.3
0.11
13
67
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
21
77
2.73
4.34
1.5
1.4
%
71.1
74.8
0.21
15
64
(3002523) Influenza virus A Ag [Presence] in Specimen
68
398
1.72
4.32
1.2
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
47
246
1.92
4.28
1.7
2.4
ml
1994.8
1898.9
0.33
39
205
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
18
61
2.96
4.27
1.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
18
61
2.96
4.27
1.3
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
45
233
1.94
4.23
1.5
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
82
508
1.62
4.21
1.7
1.3
e6/l
105988.9
110051.4
0.02
56
355
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
36
172
2.10
4.21
1.4
1.4
%
23.7
21.3
0.16
23
140
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
159
2.14
4.20
5.6
1.8
umol/l
152.9
131.6
0.17
21
97
(3045424) Erythrocytes [Presence] in Urine
122
828
1.48
4.19
1.8
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
96
619
1.56
4.18
1.5
2.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
18
62
2.91
4.16
2.1
1.4
umol/l
41.7
42.7
0.06
18
62
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
18
62
2.91
4.16
1.6
1.2
ug/l
102.4
121.9
—
10
37
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
57
2.99
4.11
1.1
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
68
404
1.69
4.11
5.8
2.3
%
10.8
10.9
0.08
68
404
(3004716) Salmonella sp identified in Stool by Organism specific culture
224
1700
1.33
4.04
1.4
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
67
399
1.69
4.02
1.2
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
62
364
1.71
3.93
1.3
1.1
mmol/l
32.5
34.6
0.36
57
305
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
68
417
1.64
3.69
1.9
1.9
u/l
5101.3
2495.0
0.27
20
157
(3005011) Chlamydia sp Ab [Titer] in Serum
15
51
2.95
3.57
1.5
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
80
515
1.56
3.56
1.4
1.3
mosm/kgh2o
272.1
277.6
1.26
70
385
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
102
1477
0.69
3.56
1.6
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
58
346
1.68
3.51
3.0
2.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
21
87
2.42
3.46
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
40
215
1.87
3.43
1.3
1.3
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
39
208
1.88
3.43
1.2
1.3
ug/l
118.5
530.0
1.07
15
108
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
47
2.98
3.41
3.6
2.6
mg/l
0.7
1.1
—
7
35
(3020393) Adenovirus Ag [Presence] in Stool
14
47
2.98
3.41
1.2
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
9
18
5.01
3.36
7.3
8.7
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
54
2.78
3.25
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
50
294
1.71
3.22
1.7
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1339
12264
1.12
3.20
1.8
1.6
mmol/l
1.4
1.3
3.77
1098
10155
(3044009) aPTT.lupus sensitive (LA screen)
10
28
3.58
3.19
1.4
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
10
28
3.58
3.19
1.5
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
35
187
1.88
3.09
2.9
2.5
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
17
4.71
2.91
1.6
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
79
1150
0.68
2.90
1.7
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
93
649
1.44
2.89
1.6
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
14
52
2.70
2.88
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
50
304
1.65
2.88
1.5
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
22
102
2.16
2.86
1.2
1.2
mg/l
0.8
47.0
0.50
14
76
(3003694) ABO and Rh group [Type] in Blood
1273
11729
1.11
2.69
1.5
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
498
4326
1.17
2.67
1.7
1.6
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
21
99
2.13
2.64
1.3
1.2
mmol/l
0.5
1.9
1.28
12
67
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
25
127
1.97
2.59
1.0
1.1
miu/ml
1727.0
1647.2
0.10
25
127
(3016135) IgD [Mass/volume] in Serum
5
7
7.15
2.55
1.4
1.3
mg/l
242.2
121.5
—
5
7
(3004775) Volume in Urine collected for unspecified duration
68
459
1.49
2.54
2.3
2.2
ml
589.9
650.1
0.63
45
279
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
11
5.46
2.54
1.3
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1650
17600
0.91
2.53
4.2
4.7
%
21.8
22.2
0.41
750
9315
(3034274) Bile acid [Moles/volume] in Serum --fasting
38
224
1.70
2.49
1.1
1.6
umol/l
5.7
11.0
1.10
28
150
(3017446) Testosterone [Moles/volume] in Serum or Plasma
420
3623
1.17
2.48
2.6
2.1
nmol/l
12.3
12.0
0.31
360
3121
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
26
3.47
2.48
1.1
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
21
3.81
2.46
1.6
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
64
430
1.49
2.46
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
189
1510
1.26
2.44
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
234
2837
0.82
2.39
4.9
3.7
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
19
90
2.11
2.38
1.3
1.2
u/l
383.8
415.8
0.03
12
63
(3041184) Isoniazid [Presence] in Urine
5
8
6.25
2.37
2.6
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
58
2.42
2.36
4.1
4.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
22
3.64
2.36
2.1
5.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
41
254
1.62
2.26
1.6
1.3
nmol/l
1.2
1.2
0.11
31
191
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
18
3.89
2.25
1.3
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
18
3.89
2.25
1.3
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
9
5.56
2.21
2.4
4.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
31
180
1.73
2.18
1.2
1.2
g/l
32.3
40.9
2.13
14
88
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
74
2.17
2.14
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
24
130
1.85
2.11
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
18
88
2.05
2.11
2.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1124
10423
1.10
2.07
5.3
4.4
kg/l
1.0
1.0
0.05
204
1619
(40758292) HTLV I+II Ab panel - Serum
14
62
2.26
2.07
1.2
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
103
782
1.32
2.02
1.4
1.4
u/l
10.1
10.5
0.11
82
631
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
50
2.40
2.02
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
58
827
0.70
2.01
1.7
1.6
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
11
44
2.50
2.01
1.3
1.2
mmol/l
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
38
2.63
2.01
1.3
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
260
2198
1.19
2.00
1.2
1.2
iu/ml
118.8
139.1
0.38
77
770
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
330
1.49
1.93
1.4
1.3
promille
1.1
1.2
0.09
38
250
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
10
39
2.57
1.92
1.0
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
15
71
2.12
1.92
1.2
1.2
u/l
19.4
19.4
—
8
49
(3048879) Bone marrow aspiration report
29
173
1.68
1.89
2.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
204
1.62
1.88
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
110
853
1.30
1.88
1.2
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
104
801
1.30
1.87
1.4
1.4
iu/l
33.5
30.4
0.37
80
684
(3019174) dRVVT (LA screen)
8
28
2.86
1.86
1.4
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
23
129
1.79
1.85
1.9
2.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
44
293
1.51
1.84
1.7
1.8
u/field
1.5
2.8
0.75
34
202
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
152
1.71
1.82
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
77
571
1.35
1.80
1.2
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
35
2.57
1.80
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
22
123
1.79
1.79
2.0
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
5069
49985
1.10
1.78
45.3
24.7
fl
92.5
91.6
27.60
5023
49033
(3035941) MCH [Entitic mass]
5069
49985
1.10
1.78
45.2
24.6
pg
30.5
30.4
0.48
5025
49033
(3007461) Platelets [#/volume] in Blood
5068
49976
1.10
1.77
45.5
24.7
e9/l
245.2
240.5
4.99
4986
48430
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
322
2803
1.16
1.77
2.4
2.4
au/ml
53.7
26.3
—
6
103
(1761482) Bacteria [#/volume] in Urine by Culture
126
1572
0.80
1.77
5.8
4.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
5069
49988
1.10
1.76
45.5
24.7
e12/l
4.4
4.4
15.33
4970
48255
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
32
200
1.60
1.76
1.1
1.2
%
60.7
62.5
—
6
27
(3010813) Leukocytes [#/volume] in Blood
5070
50000
1.10
1.76
45.5
24.8
e9/l
7.8
6.9
68.72
4974
48255
(3040893) Potassium [Moles/volume] in Capillary blood
6
18
3.34
1.74
2.8
1.9
mmol/l
4.3
4.4
—
6
18
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
292
2527
1.16
1.74
1.3
1.3
au/ml
44.8
58.3
—
8
103
(3000963) Hemoglobin [Mass/volume] in Blood
5069
50000
1.10
1.72
45.8
24.9
g/l
131.3
133.7
23.99
5024
49056
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
395
0.61
1.69
2.0
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
92
709
1.30
1.68
2.8
2.1
mg/l
24.2
25.8
0.11
31
168
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
203
1.58
1.67
1.3
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
62
451
1.38
1.66
1.5
1.6
u/ml
14.2
25.9
—
10
105
(4027681)
30
188
1.60
1.65
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
76
573
1.33
1.63
1.6
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
22
128
1.72
1.60
1.3
1.3
g/l
0.4
0.3
1.17
14
101
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
43
295
1.46
1.59
2.0
1.7
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
32
2.50
1.59
1.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
70
2.00
1.59
12.4
12.1
mmol/l
5.7
5.3
0.47
14
70
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
26
2.69
1.58
1.0
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
17
92
1.85
1.55
2.0
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
92
1.85
1.55
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
49
682
0.72
1.55
1.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
248
1.50
1.54
1.5
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
44
0.00
1.51
0.0
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
19
108
1.76
1.50
1.4
1.1
pmol/l
302.4
262.0
—
10
76
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
86
1.86
1.50
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
28
178
1.58
1.48
1.3
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
45
318
1.42
1.45
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
16
87
1.84
1.45
5.4
7.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
7
28
2.50
1.45
1.4
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
378
0.63
1.44
1.0
1.0
ng/l
313.9
327.7
0.08
13
245
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
52
2.12
1.44
1.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
46
2.18
1.39
1.2
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
10
46
2.18
1.39
1.1
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
17
2.94
1.36
1.2
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
23
143
1.61
1.34
2.1
1.9
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
21
128
1.64
1.33
1.0
1.2
%
22.7
29.0
—
6
18
(3020650) Glucose [Presence] in Urine
18
105
1.72
1.33
1.5
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
95
763
1.25
1.31
1.3
1.7
mu/l
310.7
302.2
0.10
86
701
(3008898) HLA-B27 [Presence]
122
1007
1.22
1.31
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
113
1.68
1.31
1.2
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
380
0.66
1.30
1.0
1.0
ng/l
35.4
45.0
0.41
14
243
(40765096) Chromosome analysis panel by Banding
26
169
1.54
1.28
1.1
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
378
0.66
1.28
1.0
1.0
ng/l
793.7
685.3
0.86
13
237
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
72
562
1.28
1.27
1.6
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
107
1.68
1.25
1.2
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
42
303
1.39
1.24
2.5
2.7
umol/l
23.4
34.2
—
5
27
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
228
2004
1.14
1.18
3.1
3.3
u/ml
12013.2
1554.9
0.42
186
1712
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
168
0.54
1.18
1.7
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
264
2965
0.89
1.17
1.2
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
1.6
9.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
57
735
0.77
1.15
2.0
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
56
431
1.30
1.12
1.0
1.1
u/ml
17.3
2.6
0.78
16
143
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
137
1165
1.18
1.11
3.0
3.2
u/ml
86.2
762.6
1.96
127
1060
(1761868) Lipid panel - Serum or Plasma
1277
13366
0.94
1.10
3.2
3.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
26
176
1.48
1.10
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
206
0.58
1.07
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
206
0.58
1.07
1.4
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
29
202
1.44
1.07
3.0
2.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
194
1.45
1.06
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
205
0.58
1.06
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
205
0.58
1.06
1.4
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
40
296
1.35
1.05
2.2
2.1
ug/min
61.2
208.2
—
6
78
(3028707) Methadone [Presence] in Urine by Screen method
35
254
1.38
1.04
2.5
2.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
34
2.06
1.02
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
692
6499
1.07
1.00
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1191
12454
0.95
1.00
3.0
3.2
ug/l
0.7
0.8
2.78
853
8899
(3025315) Body weight
7
36
1.95
0.97
5.3
4.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
100
1.60
0.96
1.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
62
496
1.25
0.95
1.9
1.9
g/24h
0.6
1.0
—
5
19
(3050129) First trimester maternal screen panel - Serum or Plasma
15
235
0.64
0.95
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
282
0.67
0.94
1.9
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
589
0.78
0.92
1.6
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
55
437
1.26
0.91
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
145
1264
1.15
0.91
1.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
75
618
1.22
0.90
1.5
1.3
nmol/l
12.2
0.7
0.49
69
589
(3051101) Glucose [Moles/volume] in Cord blood
5
104
0.48
0.88
2.0
5.7
—
—
—
0
0
(4034850)
173
1532
1.13
0.87
13.0
11.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
34
255
1.34
0.86
1.1
1.1
mg/l
279.0
296.0
0.26
29
218
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
216
0.65
0.85
1.4
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
75
623
1.21
0.84
1.5
1.3
nmol/l
0.2
0.3
—
8
45
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
110
951
1.16
0.80
1.1
1.2
mmol/l
3.8
3.9
0.40
101
881
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
30
224
1.34
0.79
1.4
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
58
1.73
0.79
1.7
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
58
1.73
0.79
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
127
1448
0.87
0.78
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
175
0.63
0.78
1.4
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
82
1.59
0.78
1.1
1.1
u/ml
1.2
52.9
—
8
35
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
35
269
1.30
0.77
1.2
1.1
mg/l
51.0
44.4
0.32
28
221
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
197
1780
1.11
0.74
1.5
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
77
652
1.18
0.73
3.2
3.8
u/ml
27.6
32.2
0.34
72
631
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
241
2205
1.10
0.71
2.4
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
123
1084
1.14
0.71
1.2
1.3
mg/l
740.2
548.5
0.40
112
1018
(3025130) Human papilloma virus identified in Specimen
36
284
1.27
0.67
1.9
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
168
0.65
0.67
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
91
0.55
0.67
1.8
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
223
1.30
0.66
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
167
0.66
0.65
1.3
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
78
1.54
0.65
2.1
1.7
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
44
1.59
0.65
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
646
0.83
0.64
3.3
4.4
umol/l
325.2
346.3
0.45
42
548
(3015183) Erythrocyte sedimentation rate
20
146
1.37
0.63
1.2
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
63
1.59
0.61
1.7
2.7
u/field
0.4
0.3
—
10
63
(3036525) Urea [Moles/time] in 24 hour Urine
5
30
1.67
0.61
2.4
3.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
416
1.20
0.60
2.2
1.8
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
272.8
—
0
20
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
64
546
1.17
0.59
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
23
300
0.77
0.59
1.2
1.4
u/l
24.7
30.6
0.57
18
245
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
184
1.31
0.57
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
63
540
1.17
0.56
2.0
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
63
542
1.16
0.54
2.0
1.9
—
—
—
0
0
(4281824)
36
438
0.82
0.54
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
36
294
1.23
0.54
1.8
1.4
nmol/l
0.2
0.3
1.96
27
219
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
30
241
1.25
0.52
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
20
152
1.32
0.52
1.1
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
89
790
1.13
0.51
3.6
2.4
mmol/l
4.1
4.1
0.17
89
780
(3035285) Chloride [Moles/volume] in Venous blood
89
790
1.13
0.51
3.6
2.4
mmol/l
105.3
105.6
0.23
89
780
(3008116) Ketones [Moles/volume] in Urine by Test strip
15
109
1.38
0.50
1.7
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
30
242
1.24
0.50
3.7
6.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
58
501
1.16
0.49
2.1
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
94
840
1.12
0.49
1.3
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
144
0.69
0.49
1.6
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
87
775
1.12
0.48
3.7
2.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
190
1.26
0.47
1.0
1.1
u/l
1.1
1.2
0.96
15
99
(3027944) Amphetamines [Presence] in Urine
61
531
1.15
0.47
1.9
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
63
550
1.15
0.47
1.5
1.3
nmol/l
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
65
569
1.14
0.47
1.2
1.3
pmol/l
282.5
259.9
0.18
51
424
(3049717) Cytology report of Urine Cyto stain
272
2558
1.07
0.47
2.9
2.9
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
56
486
1.15
0.46
1.8
2.1
u/field
1.7
1.7
0.02
28
174
(3019225) pH of Specimen
571
5486
1.05
0.45
5.2
4.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
223
2087
1.07
0.45
1.4
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
102
923
1.11
0.44
1.2
1.4
e6/l
84.5
966.3
3.73
78
756
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
86
771
1.12
0.44
2.0
1.9
pmol/l
201.6
200.4
0.04
76
716
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
40
339
1.18
0.44
3.5
5.0
u/ml
91.8
59.4
0.24
11
95
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
61
537
1.14
0.42
2.0
1.9
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
70
1.43
0.41
2.2
2.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
70
1.43
0.41
2.2
2.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
15
0.00
0.41
0.0
1.1
—
7.8
—
0
15
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
59
1.36
0.41
1.1
1.5
—
—
—
0
0
(4198724)
12
88
1.36
0.40
1.2
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
19
151
1.26
0.38
20.7
16.5
nmol/l
1407.7
1422.5
0.03
19
146
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
101
923
1.10
0.38
1.2
1.4
e6/l
18.7
21.3
0.08
69
720
(3025577) Chromium [Mass/volume] in Blood
44
382
1.15
0.38
1.6
2.0
ug/l
1.6
2.2
1.25
38
318
(40761535) Cells panel - Urine sediment
465
4473
1.04
0.37
4.5
3.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
170
1.24
0.37
1.2
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
116
1.29
0.37
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
354
3387
1.05
0.36
4.2
3.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4545
45720
0.97
0.36
5.4
5.3
mmol/l
2.5
2.6
10.01
4067
41250
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
30
254
1.18
0.35
4.9
4.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
108
1168
0.92
0.34
3.1
2.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
19
154
1.23
0.33
1.8
1.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
45
1.33
0.33
1.0
1.2
u/l
7.8
11.6
—
6
45
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
46
1.30
0.33
1.0
1.0
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
6
47
1.28
0.32
1.8
1.3
—
640.5
—
0
9
(40768793) Breast Pathology biopsy report
94
866
1.09
0.32
1.5
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
11
83
1.33
0.32
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4427
44520
0.98
0.32
4.9
4.7
mmol/l
4.4
4.5
6.11
3962
40374
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4385
44098
0.98
0.31
4.8
4.7
mmol/l
1.4
1.4
3.85
3896
39682
(3023410) Appearance of Cerebral spinal fluid
45
399
1.13
0.31
1.3
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
107
1151
0.93
0.30
6.5
3.8
mg/l
28.4
30.0
0.19
80
747
(3044007) Cell count panel - Peritoneal fluid
18
147
1.23
0.30
1.7
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4509
44851
1.02
0.30
5.3
5.1
mmol/l
6.1
6.1
0.46
4053
40025
(4211845)
32
278
1.15
0.29
4.7
3.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
169
1599
1.06
0.29
1.6
1.7
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
17
139
1.22
0.29
1.6
1.4
pmol/l
17.9
16.6
—
10
109
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
130
1.23
0.28
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
68
622
1.09
0.28
1.7
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
117
0.77
0.27
1.3
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
41
366
1.12
0.26
2.9
3.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
113
1.24
0.26
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
2.5
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
33
291
1.13
0.26
2.4
2.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
16
133
1.20
0.24
1.0
1.1
u/ml
0.8
2.3
—
8
44
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
44
398
1.11
0.24
1.1
1.1
—
27.8
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
124
1.21
0.24
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
70
649
1.08
0.23
1.1
1.1
iu/ml
73.1
66.1
0.04
16
132
(3026692) Albumin [Mass/volume] in Peritoneal fluid
17
143
1.19
0.23
1.5
1.7
g/l
12.6
14.6
0.35
12
112
(3011985) Renin [Units/volume] in Plasma
66
611
1.08
0.23
1.3
1.4
mu/l
51.2
59.3
0.21
58
532
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
168
0.83
0.22
1.4
2.1
e6/l
1716.2
19693.3
—
5
102
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
125
1.20
0.22
1.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
52
477
1.09
0.22
1.2
1.2
mmol/l
7.3
7.7
0.38
36
341
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
116
1.21
0.22
1.1
1.1
—
—
—
0
0
(4094501)
119
1255
0.95
0.22
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
2.2
2.1
umol/l
15.6
18.1
—
5
42
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
42
1.19
0.21
1.2
4.3
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.8
—
0
6
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
11
0.00
0.21
0.0
6.9
—
45.3
—
0
11
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
2.2
—
0
12
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
49
1.22
0.20
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
115
0.78
0.20
1.1
1.4
—
—
—
0
0
(4212803)
6
52
1.15
0.19
1.2
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
52
1.15
0.19
14.7
10.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
420
4300
0.97
0.19
1.4
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
17
147
1.16
0.18
17.3
11.5
nmol/l
888.6
817.6
0.24
17
137
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
268
0.90
0.17
1.5
1.4
pmol/l
60.2
165.3
—
9
87
(3051593) INR in Capillary blood by Coagulation assay
29
320
0.91
0.17
6.8
12.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2180
21964
0.99
0.16
4.8
5.4
ug/l
3.6
4.0
0.21
1888
19485
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
98
0.82
0.13
1.5
1.5
ng/l
183.9
159.3
—
8
98
(4133840)
8
100
0.80
0.13
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
95
911
1.04
0.13
1.9
1.5
nmol/l
1.1
0.8
1.93
76
751
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
25
228
1.10
0.13
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
238
1.09
0.13
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
19
171
1.11
0.12
1.2
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
12
137
0.88
0.12
2.0
2.2
ug/l
1.3
1.3
0.01
12
129
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
189
0.90
0.12
1.9
2.3
e6/l
326.0
4785.1
—
10
137
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
188
1833
1.03
0.12
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
20
220
0.91
0.12
1.4
1.3
mmol/l
6.1
6.1
0.07
20
205
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
17
188
0.90
0.11
2.0
2.2
umol/l
65.7
56.0
0.37
11
151
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
21
228
0.92
0.10
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
116
1.12
0.09
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
37
350
1.06
0.09
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
56
1.07
0.08
1.3
2.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
70
0.86
0.07
2.5
2.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
98
1.12
0.07
1.5
1.2
umol/24h
0.8
0.7
—
5
50
(3000034) Microalbumin [Mass/volume] in Urine
52
500
1.04
0.07
2.3
3.2
mg/l
63.4
47.3
0.24
41
384
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
30
317
0.95
0.07
1.1
1.2
mmol/l
13.9
11.8
0.58
15
96
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
115
1123
1.02
0.07
2.0
1.7
mg/l
28.3
3.5
6.49
99
801
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
72
742
0.97
0.07
1.6
1.5
pmol/l
168.2
234.0
0.68
72
719
(3002619) Bacteria identified in Specimen by Culture
8
90
0.89
0.06
1.5
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
176
1789
0.98
0.06
3.3
3.8
u/ml
60.7
74.8
0.35
171
1715
(3003338) MCHC [Mass/volume]
3682
36758
1.00
0.05
41.1
22.1
g/l
329.3
331.8
50.86
3656
36378
(4024509)
57
554
1.03
0.05
1.6
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
28
293
0.96
0.05
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
18
169
1.07
0.05
2.2
1.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
120
0.92
0.05
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
12
130
0.92
0.04
1.6
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
110
1082
1.02
0.04
1.6
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
34
352
0.97
0.04
10.3
2.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
101
1.09
0.04
1.2
1.1
—
—
—
0
0
(4146454)
65
638
1.02
0.03
2.4
2.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
141
1396
1.01
0.02
2.6
2.3
ug/min
130.0
102.9
0.37
86
811
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
132
1.06
0.02
2.0
2.2
mmol/l
7.6
8.1
—
9
82
(3006270) Folate [Moles/volume] in Blood
47
480
0.98
0.02
1.1
1.2
nmol/l
295.2
337.6
0.70
36
379
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4268
42652
1.00
0.02
4.3
4.2
mmol/l
1.3
1.3
7.80
3771
38010
(44806420)
19
198
0.96
0.02
2.0
2.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
102
0.98
0.00
1.9
3.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
205
1.02
0.00
1.2
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
93
932
1.00
0.00
1.8
1.7
iu/l
4.8
4.8
0.00
26
290
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
124
0.97
0.00
1.0
1.1
u/ml
0.6
2.8
—
5
36
(3024869) Neuronal Ab [Presence] in Serum
11
111
0.99
0.00
1.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
1364.4
—
0
9
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
7.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(4038314)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
93
0.97
0.00
1.2
1.2
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.2
—
0.3
—
0
5
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
49
1.02
0.00
1.2
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
50
1.00
0.00
2.2
1.1
umol/24h
1.9
1.8
—
5
50
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
2864.4
—
0
9
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
40.0
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3044336) Cobalt [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
16.6
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: J10_OTHERINSTPULM – Other interstitial pulmonary diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).